{
  "protocolId": "NCT00481091",
  "version": "2.0",
  "generatedAt": "2026-02-13T14:26:12.069206",
  "atomicCriteria": [
    {
      "atomicId": "A0001",
      "originalCriterionId": "INC_5.2.1.1",
      "criterionType": "inclusion",
      "atomicText": "Age >= 18 years",
      "normalizedText": "Age >= 18 years",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4265453
        ],
        "conceptNames": [
          "Age"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "397669002"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 18"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "30525-0",
            "display": "Age"
          }
        ],
        "searchParams": "code=http://loinc.org|30525-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.1_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 1
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "5.2.1 Phase 1 Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0002",
      "originalCriterionId": "INC_5.2.1.2",
      "criterionType": "inclusion",
      "atomicText": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
      "normalizedText": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4173824
        ],
        "conceptNames": [
          "B-cell chronic lymphocytic leukemia variant"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "277474005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "277474005",
            "display": "B-cell chronic lymphocytic leukemia variant"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C91.1",
            "display": "Chronic lymphocytic leukemia of B-cell type"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.2_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 2
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "cll_relapsed_refractory_status",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0003",
      "originalCriterionId": "INC_5.2.1.2",
      "criterionType": "inclusion",
      "atomicText": "Refractory Chronic Lymphocytic Leukemia (CLL)",
      "normalizedText": "Refractory Chronic Lymphocytic Leukemia (CLL)",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4173824
        ],
        "conceptNames": [
          "B-cell chronic lymphocytic leukemia variant"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "277474005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "277474005",
            "display": "B-cell chronic lymphocytic leukemia variant"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C91.1",
            "display": "Chronic lymphocytic leukemia of B-cell type"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.2_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 3
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "cll_relapsed_refractory_status",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0004",
      "originalCriterionId": "INC_5.2.1.2",
      "criterionType": "inclusion",
      "atomicText": "Requires treatment in the opinion of the investigator",
      "normalizedText": "Requires treatment in the opinion of the investigator",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.9,
        "impactScore": 0.9990000000000001,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.2_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 4
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have relapsed or refractory CLL and require treatment in the \nopinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0005",
      "originalCriterionId": "INC_5.2.1.3",
      "criterionType": "inclusion",
      "atomicText": "Eastern Cooperative Oncology Group performance score of <= 1",
      "normalizedText": "Eastern Cooperative Oncology Group performance score of <= 1",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.3_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 5
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "opinion of the investigator.\n3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "performance_status",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0006",
      "originalCriterionId": "INC_5.2.1.4",
      "criterionType": "inclusion",
      "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
      "normalizedText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.4_1a_condition",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 6
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n4. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a_condition"
    },
    {
      "atomicId": "A0007",
      "originalCriterionId": "INC_5.2.1.4",
      "criterionType": "inclusion",
      "atomicText": "Receiving a stable dose of SSRI anti-depressant",
      "normalizedText": "Receiving a stable dose of SSRI anti-depressant",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '21 days'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.4_1b_requirement",
        "groupLogic": "IMPLICATION_REQUIREMENT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 7
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "3. The subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n4. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b_requirement"
    },
    {
      "atomicId": "A0008",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
      "normalizedText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 1000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1a1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 8
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0009",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Platelets >= 75,000/mm3",
      "normalizedText": "Platelets >= 75,000/mm3",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 75000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1a2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 9
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a2a"
    },
    {
      "atomicId": "A0010",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Received platelet transfusion",
      "normalizedText": "Received platelet transfusion",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1a2b1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 10
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a2b1a"
    },
    {
      "atomicId": "A0011",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Hemoglobin >= 9.0 g/dL",
      "normalizedText": "Hemoglobin >= 9.0 g/dL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3000963
        ],
        "conceptNames": [
          "Hemoglobin [Mass/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "718-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 9.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|718-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1a3",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 11
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a3"
    },
    {
      "atomicId": "A0012",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Received growth factor support",
      "normalizedText": "Received growth factor support",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1a4a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 12
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a4a"
    },
    {
      "atomicId": "A0013",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
      "normalizedText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number < 1000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 13
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0014",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Bone marrow heavily infiltrated with underlying disease (80% or more)",
      "normalizedText": "Bone marrow heavily infiltrated with underlying disease (80% or more)",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number >= 80"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_1b2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 14
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b2"
    },
    {
      "atomicId": "A0015",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Serum creatinine <= 2.0 mg/dL",
      "normalizedText": "Serum creatinine <= 2.0 mg/dL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "2160-0"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 2.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 15
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0016",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Calculated creatinine clearance >= 50 mL/min",
      "normalizedText": "Calculated creatinine clearance >= 50 mL/min",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "2160-0"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 50"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 16
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0017",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "AST <= 3.0 x the upper normal limit (ULN)",
      "normalizedText": "AST <= 3.0 x the upper normal limit (ULN)",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013721
        ],
        "conceptNames": [
          "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1920-8"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1920-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_3a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 17
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3a"
    },
    {
      "atomicId": "A0018",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "ALT <= 3.0 x the upper normal limit (ULN)",
      "normalizedText": "ALT <= 3.0 x the upper normal limit (ULN)",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3006923
        ],
        "conceptNames": [
          "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1742-6"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1742-6",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_3b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 18
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3b"
    },
    {
      "atomicId": "A0019",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Total Bilirubin <= 1.5 x ULN",
      "normalizedText": "Total Bilirubin <= 1.5 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1975-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_3c1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 19
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3c1"
    },
    {
      "atomicId": "A0020",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "Subject has Gilbert's Syndrome",
      "normalizedText": "Subject has Gilbert's Syndrome",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4099740
        ],
        "conceptNames": [
          "Gilbert's syndrome"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "27503000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "27503000",
            "display": "Gilbert's syndrome"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E80.4",
            "display": "Gilbert syndrome"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_3c2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 20
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "3c2"
    },
    {
      "atomicId": "A0021",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "aPTT not to exceed 1.2 x ULN",
      "normalizedText": "aPTT not to exceed 1.2 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013466
        ],
        "conceptNames": [
          "aPTT in Blood by Coagulation assay"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "3173-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.2"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "3173-2",
            "display": "aPTT in Blood by Coagulation assay"
          }
        ],
        "searchParams": "code=http://loinc.org|3173-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_4a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 21
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4a"
    },
    {
      "atomicId": "A0022",
      "originalCriterionId": "INC_5.2.1.5",
      "criterionType": "inclusion",
      "atomicText": "PT not to exceed 1.2 x ULN",
      "normalizedText": "PT not to exceed 1.2 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3034426
        ],
        "conceptNames": [
          "Prothrombin time (PT)"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "5902-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.2"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "5902-2",
            "display": "Prothrombin time (PT)"
          }
        ],
        "searchParams": "code=http://loinc.org|5902-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.5_4b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 22
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "first dose of study drug.\n5. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening),...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4b"
    },
    {
      "atomicId": "A0023",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "Subject is female",
      "normalizedText": "Subject is female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 23
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0024",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile",
      "normalizedText": "Surgically sterile",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 24
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0025",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "Postmenopausal for at least 1 year",
      "normalizedText": "Postmenopausal for at least 1 year",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 25
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0026",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "Positive serum pregnancy test result at Screening",
      "normalizedText": "Positive serum pregnancy test result at Screening",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for serum hCG test.",
        "sqlExecutable": true,
        "valueConstraint": "Positive result for serum hCG test."
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_2c1a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 26
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "2c1a1"
    },
    {
      "atomicId": "A0027",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
      "normalizedText": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_2c2_cond",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 27
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "2c2_cond"
    },
    {
      "atomicId": "A0028",
      "originalCriterionId": "INC_5.2.1.6",
      "criterionType": "inclusion",
      "atomicText": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
      "normalizedText": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive result for urine hCG test.",
        "sqlExecutable": true,
        "valueConstraint": "Positive result for urine hCG test."
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.6_2c2_req_a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 28
      },
      "provenance": {
        "pageNumber": 28,
        "textSnippet": "\u25cf Coagulation: aPTT, PT, not to exceed 1.2 \uf0b4 ULN.\n6. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "2c2_req_a1"
    },
    {
      "atomicId": "A0029",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Gender is Female",
      "normalizedText": "Gender is Female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Gender is Female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_c1a1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 29
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "c1a1"
    },
    {
      "atomicId": "A0030",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile",
      "normalizedText": "Surgically sterile",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_c1a2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 30
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "female_sterility",
      "expressionNodeId": "c1a2a"
    },
    {
      "atomicId": "A0031",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Postmenopausal for at least 1 year",
      "normalizedText": "Postmenopausal for at least 1 year",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_c1a2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 31
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "female_sterility",
      "expressionNodeId": "c1a2b"
    },
    {
      "atomicId": "A0032",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Gender is Male",
      "normalizedText": "Gender is Male",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Gender is Male\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_c1b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 32
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "c1b1"
    },
    {
      "atomicId": "A0033",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Subject has had a vasectomy",
      "normalizedText": "Subject has had a vasectomy",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_c1b2a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 33
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "c1b2a"
    },
    {
      "atomicId": "A0034",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Total abstinence from sexual intercourse for at least one complete menstrual cycle",
      "normalizedText": "Total abstinence from sexual intercourse for at least one complete menstrual cycle",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_r1a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 34
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "birth_control_method",
      "expressionNodeId": "r1a"
    },
    {
      "atomicId": "A0035",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Partner is vasectomized",
      "normalizedText": "Partner is vasectomized",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_r1b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 35
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "birth_control_method",
      "expressionNodeId": "r1b"
    },
    {
      "atomicId": "A0036",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
      "normalizedText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600058216
        ],
        "conceptNames": [
          "Other Investigational Agent"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C156875"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C156875",
            "display": "Other Investigational Agent"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_r1c",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 36
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "birth_control_method",
      "expressionNodeId": "r1c"
    },
    {
      "atomicId": "A0037",
      "originalCriterionId": "INC_5.2.1.7",
      "criterionType": "inclusion",
      "atomicText": "Use of double-barrier method",
      "normalizedText": "Use of double-barrier method",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.7_r1d",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 37
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "test results.\n7. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;\n\u25cf double-barrier method (including condoms, contraceptive spo...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "birth_control_method",
      "expressionNodeId": "r1d"
    },
    {
      "atomicId": "A0038",
      "originalCriterionId": "INC_5.2.1.8",
      "criterionType": "inclusion",
      "atomicText": "Informed consent was given voluntarily",
      "normalizedText": "Informed consent was given voluntarily",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.8_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 38
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0039",
      "originalCriterionId": "INC_5.2.1.8",
      "criterionType": "inclusion",
      "atomicText": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
      "normalizedText": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.8_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 39
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0040",
      "originalCriterionId": "INC_5.2.1.8",
      "criterionType": "inclusion",
      "atomicText": "Subject has signed an informed consent form",
      "normalizedText": "Subject has signed an informed consent form",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.8_3a1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 40
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "informed_consent_documentation",
      "expressionNodeId": "3a1"
    },
    {
      "atomicId": "A0041",
      "originalCriterionId": "INC_5.2.1.8",
      "criterionType": "inclusion",
      "atomicText": "The signed informed consent form is dated",
      "normalizedText": "The signed informed consent form is dated",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.1.8_3a2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 41
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "or vaginal ring with spermicidal jellies or cream).\n8. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "informed_consent_documentation",
      "expressionNodeId": "3a2"
    },
    {
      "atomicId": "A0042",
      "originalCriterionId": "EXC_5.2.2.1",
      "criterionType": "exclusion",
      "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
      "normalizedText": "History of cancer-related Central Nervous System (CNS) disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600055953
        ],
        "conceptNames": [
          "Prior Invasive Malignancy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C154619"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C154619",
            "display": "Prior Invasive Malignancy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.1_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 42
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "5.2.2 Phase 1 Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "cancer_related_cns_disease",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0043",
      "originalCriterionId": "EXC_5.2.2.1",
      "criterionType": "exclusion",
      "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
      "normalizedText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.1_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 43
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "5.2.2 Phase 1 Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cancer_related_cns_disease",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0044",
      "originalCriterionId": "EXC_5.2.2.2",
      "criterionType": "exclusion",
      "atomicText": "Undergone an allogeneic stem cell transplant",
      "normalizedText": "Undergone an allogeneic stem cell transplant",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4028623
        ],
        "conceptNames": [
          "Transplantation of bone marrow"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "23719005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "23719005",
            "display": "Transplantation of bone marrow"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|23719005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.2_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 44
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "Nervous System (CNS) disease.\n2. The subject has undergone an allogeneic or autologous stem cell transplant.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "stem_cell_transplant",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0045",
      "originalCriterionId": "EXC_5.2.2.2",
      "criterionType": "exclusion",
      "atomicText": "Undergone an autologous stem cell transplant",
      "normalizedText": "Undergone an autologous stem cell transplant",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4028623
        ],
        "conceptNames": [
          "Transplantation of bone marrow"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "23719005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "23719005",
            "display": "Transplantation of bone marrow"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|23719005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.2_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 45
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "Nervous System (CNS) disease.\n2. The subject has undergone an allogeneic or autologous stem cell transplant.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "stem_cell_transplant",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0046",
      "originalCriterionId": "EXC_5.2.2.3",
      "criterionType": "exclusion",
      "atomicText": "Underlying, predisposing condition of bleeding",
      "normalizedText": "Underlying, predisposing condition of bleeding",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.3_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 46
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "2. The subject has undergone an allogeneic or autologous stem cell transplant.\n3. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0047",
      "originalCriterionId": "EXC_5.2.2.3",
      "criterionType": "exclusion",
      "atomicText": "Currently exhibits signs of bleeding",
      "normalizedText": "Currently exhibits signs of bleeding",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.3_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 47
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "2. The subject has undergone an allogeneic or autologous stem cell transplant.\n3. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0048",
      "originalCriterionId": "EXC_5.2.2.4",
      "criterionType": "exclusion",
      "atomicText": "Active peptic ulcer disease",
      "normalizedText": "Active peptic ulcer disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.4_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 48
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gi_bleeding_risk",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0049",
      "originalCriterionId": "EXC_5.2.2.4",
      "criterionType": "exclusion",
      "atomicText": "Potentially hemorrhagic esophagitis",
      "normalizedText": "Potentially hemorrhagic esophagitis",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.4_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 49
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "gi_bleeding_risk",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0050",
      "originalCriterionId": "EXC_5.2.2.4",
      "criterionType": "exclusion",
      "atomicText": "Potentially hemorrhagic gastritis",
      "normalizedText": "Potentially hemorrhagic gastritis",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.4_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 50
      },
      "provenance": {
        "pageNumber": 29,
        "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "gi_bleeding_risk",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0051",
      "originalCriterionId": "EXC_5.2.2.5",
      "criterionType": "exclusion",
      "atomicText": "Active immune thrombocytopenic purpura",
      "normalizedText": "Active immune thrombocytopenic purpura",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.5_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 51
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0052",
      "originalCriterionId": "EXC_5.2.2.5",
      "criterionType": "exclusion",
      "atomicText": "History of being refractory to platelet transfusions",
      "normalizedText": "History of being refractory to platelet transfusions",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.5_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 52
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0053",
      "originalCriterionId": "EXC_5.2.2.6",
      "criterionType": "exclusion",
      "atomicText": "Received aspirin",
      "normalizedText": "Received aspirin",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.6_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 53
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "refractory to platelet transfusions (within 1 year prior to the first dose of study \ndrug).\n6. The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0054",
      "originalCriterionId": "EXC_5.2.2.7",
      "criterionType": "exclusion",
      "atomicText": "Currently receiving or requires anticoagulation therapy",
      "normalizedText": "Currently receiving or requires anticoagulation therapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.7_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 54
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "bleeding_risk_medication",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0055",
      "originalCriterionId": "EXC_5.2.2.7",
      "criterionType": "exclusion",
      "atomicText": "Currently receiving or requires any drugs or herbal supplements that affect platelet function",
      "normalizedText": "Currently receiving or requires any drugs or herbal supplements that affect platelet function",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.7_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 55
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "bleeding_risk_medication",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0056",
      "originalCriterionId": "EXC_5.2.2.7",
      "criterionType": "exclusion",
      "atomicText": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
      "normalizedText": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "low-dose and for catheter patency"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.7_2",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 56
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "6. The subject has received aspirin within 7 days prior to the first dose of study drug.\n7. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0057",
      "originalCriterionId": "EXC_5.2.2.8",
      "criterionType": "exclusion",
      "atomicText": "Received steroid therapy for anti-neoplastic intent",
      "normalizedText": "Received steroid therapy for anti-neoplastic intent",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.8_1a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 57
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0058",
      "originalCriterionId": "EXC_5.2.2.8",
      "criterionType": "exclusion",
      "atomicText": "Received inhaled steroids for asthma",
      "normalizedText": "Received inhaled steroids for asthma",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.8_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 58
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "permitted_steroids",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0059",
      "originalCriterionId": "EXC_5.2.2.8",
      "criterionType": "exclusion",
      "atomicText": "Received topical steroids",
      "normalizedText": "Received topical steroids",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.8_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 59
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "permitted_steroids",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0060",
      "originalCriterionId": "EXC_5.2.2.8",
      "criterionType": "exclusion",
      "atomicText": "Received replacement or stress corticosteroids",
      "normalizedText": "Received replacement or stress corticosteroids",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.8_2c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 60
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "intravenous catheter.\n8. Subject has received steroid therapy for anti-neoplastic intent within 7 days prior to \nthe first dose of study drug with the exception of inhaled steroids for asthma, \ntopical steroids, or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "permitted_steroids",
      "expressionNodeId": "2c"
    },
    {
      "atomicId": "A0061",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received chemotherapy",
      "normalizedText": "Received chemotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 61
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0062",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received immunotherapy",
      "normalizedText": "Received immunotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 62
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0063",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received radiotherapy",
      "normalizedText": "Received radiotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 63
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a3"
    },
    {
      "atomicId": "A0064",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received hormonal anti-cancer therapy",
      "normalizedText": "Received hormonal anti-cancer therapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a4a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 64
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a4a"
    },
    {
      "atomicId": "A0065",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received hormones for thyroid conditions",
      "normalizedText": "Received hormones for thyroid conditions",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a4b1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 65
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a4b1"
    },
    {
      "atomicId": "A0066",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received estrogen replacement therapy (ERT)",
      "normalizedText": "Received estrogen replacement therapy (ERT)",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a4b2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 66
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a4b2"
    },
    {
      "atomicId": "A0067",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Received any investigational therapy",
      "normalizedText": "Received any investigational therapy",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_1a5",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 67
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a5"
    },
    {
      "atomicId": "A0068",
      "originalCriterionId": "EXC_5.2.2.9",
      "criterionType": "exclusion",
      "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
      "normalizedText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number < 2"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.9_2a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 68
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "topical steroids, or replacement/stress corticosteroids.\n9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0069",
      "originalCriterionId": "EXC_5.2.2.10",
      "criterionType": "exclusion",
      "atomicText": "Received a biologic",
      "normalizedText": "Received a biologic",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.10_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 69
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0070",
      "originalCriterionId": "EXC_5.2.2.11",
      "criterionType": "exclusion",
      "atomicText": "Consumed grapefruit",
      "normalizedText": "Consumed grapefruit",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.11_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 70
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "grapefruit_consumption",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0071",
      "originalCriterionId": "EXC_5.2.2.11",
      "criterionType": "exclusion",
      "atomicText": "Consumed grapefruit products",
      "normalizedText": "Consumed grapefruit products",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.11_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 71
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "grapefruit_consumption",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0072",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of cardiovascular disease",
      "normalizedText": "Significant history of cardiovascular disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 72
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0073",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Myocardial infarction",
      "normalizedText": "Myocardial infarction",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1b1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 73
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "recent_thromboembolic_events",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0074",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Thrombotic event",
      "normalizedText": "Thrombotic event",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1b2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 74
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "recent_thromboembolic_events",
      "expressionNodeId": "1b2"
    },
    {
      "atomicId": "A0075",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Thromboembolic event",
      "normalizedText": "Thromboembolic event",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '6 months'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1b3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 75
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "recent_thromboembolic_events",
      "expressionNodeId": "1b3"
    },
    {
      "atomicId": "A0076",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of renal disease",
      "normalizedText": "Significant history of renal disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 76
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1c"
    },
    {
      "atomicId": "A0077",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of neurologic disease",
      "normalizedText": "Significant history of neurologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1d",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 77
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1d"
    },
    {
      "atomicId": "A0078",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of psychiatric disease",
      "normalizedText": "Significant history of psychiatric disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1e",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 78
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1e"
    },
    {
      "atomicId": "A0079",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of endocrinologic disease",
      "normalizedText": "Significant history of endocrinologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1f",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 79
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1f"
    },
    {
      "atomicId": "A0080",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of metabolic disease",
      "normalizedText": "Significant history of metabolic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1g",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 80
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1g"
    },
    {
      "atomicId": "A0081",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of immunologic disease",
      "normalizedText": "Significant history of immunologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1h",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 81
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1h"
    },
    {
      "atomicId": "A0082",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of hepatic disease",
      "normalizedText": "Significant history of hepatic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_1i",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 82
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1i"
    },
    {
      "atomicId": "A0083",
      "originalCriterionId": "EXC_5.2.2.12",
      "criterionType": "exclusion",
      "atomicText": "Condition would adversely affect study participation in the opinion of the investigator",
      "normalizedText": "Condition would adversely affect study participation in the opinion of the investigator",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.12_2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 83
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0084",
      "originalCriterionId": "EXC_5.2.2.13",
      "criterionType": "exclusion",
      "atomicText": "Female",
      "normalizedText": "Female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.13_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 84
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0085",
      "originalCriterionId": "EXC_5.2.2.13",
      "criterionType": "exclusion",
      "atomicText": "Pregnant",
      "normalizedText": "Pregnant",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.13_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 85
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0086",
      "originalCriterionId": "EXC_5.2.2.13",
      "criterionType": "exclusion",
      "atomicText": "Breast-feeding",
      "normalizedText": "Breast-feeding",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.2.13_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 86
      },
      "provenance": {
        "pageNumber": 30,
        "textSnippet": "disease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0087",
      "originalCriterionId": "INC_5.2.3.1",
      "criterionType": "inclusion",
      "atomicText": "Age >= 18 years",
      "normalizedText": "Age >= 18 years",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          4265453
        ],
        "conceptNames": [
          "Age"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "397669002"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM person WHERE EXTRACT(YEAR FROM AGE(CURRENT_DATE, birth_datetime)) >= 18",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 18"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "30525-0",
            "display": "Age"
          }
        ],
        "searchParams": "code=http://loinc.org|30525-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.1_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 87
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "5.2.3 Phase 2a Inclusion Criteria\nA subject will be eligible for study participation if he/she meets the following criteria:\n1. The subject must be \u2265 18 years of age.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0088",
      "originalCriterionId": "INC_5.2.3.2",
      "criterionType": "inclusion",
      "atomicText": "Has Chronic Lymphocytic Leukemia (CLL)",
      "normalizedText": "Has Chronic Lymphocytic Leukemia (CLL)",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.0,
        "impactScore": 0.99,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4173824
        ],
        "conceptNames": [
          "B-cell chronic lymphocytic leukemia variant"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "277474005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4173824)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "277474005",
            "display": "B-cell chronic lymphocytic leukemia variant"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C91.1",
            "display": "Chronic lymphocytic leukemia of B-cell type"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|277474005,C91.1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.2_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 88
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have CLL and require treatment in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0089",
      "originalCriterionId": "INC_5.2.3.2",
      "criterionType": "inclusion",
      "atomicText": "Requires treatment in the opinion of the investigator",
      "normalizedText": "Requires treatment in the opinion of the investigator",
      "category": "primary_anchor",
      "funnelImpact": {
        "eliminationRate": 99.0,
        "impactScore": 0.99,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.2_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 89
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "1. The subject must be \u2265 18 years of age.\n2. The subject must have CLL and require treatment in the opinion of the investigator.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0090",
      "originalCriterionId": "INC_5.2.3.3",
      "criterionType": "inclusion",
      "atomicText": "Relapsed disease",
      "normalizedText": "Relapsed disease",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.3_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 90
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "2. The subject must have CLL and require treatment in the opinion of the investigator.\n3. The subject has relapsed disease and has received no more than 5 prior \nmyelosuppressive/chemotherapy regimens.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0091",
      "originalCriterionId": "INC_5.2.3.3",
      "criterionType": "inclusion",
      "atomicText": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
      "normalizedText": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number <= 5"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.3_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 91
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "2. The subject must have CLL and require treatment in the opinion of the investigator.\n3. The subject has relapsed disease and has received no more than 5 prior \nmyelosuppressive/chemotherapy regimens.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0092",
      "originalCriterionId": "INC_5.2.3.4",
      "criterionType": "inclusion",
      "atomicText": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1",
      "normalizedText": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          36305384
        ],
        "conceptNames": [
          "ECOG Performance Status score"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "89247-1"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 36305384 AND value_as_number >= 0 AND value_as_number <= 1",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 0 AND value_as_number <= 1"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "89247-1",
            "display": "ECOG Performance Status score"
          }
        ],
        "searchParams": "code=http://loinc.org|89247-1",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.4_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 92
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "myelosuppressive/chemotherapy regimens.\n4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "performance_status",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0093",
      "originalCriterionId": "INC_5.2.3.5",
      "criterionType": "inclusion",
      "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
      "normalizedText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.5_1a",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 93
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n5. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "ssri_therapy",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0094",
      "originalCriterionId": "INC_5.2.3.5",
      "criterionType": "inclusion",
      "atomicText": "Dose of SSRI changed",
      "normalizedText": "Dose of SSRI changed",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.5_1b1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 94
      },
      "provenance": {
        "pageNumber": 31,
        "textSnippet": "4. Subject has an Eastern Cooperative Oncology Group performance score of \uf0a3 1.\n5. Subjects receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants \n(e.g., Prozac) must be receiving a stable dose for at least 21 days prior to the \nfirst dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "ssri_therapy",
      "expressionNodeId": "1b1a"
    },
    {
      "atomicId": "A0095",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Received growth factor support to maintain bone marrow function",
      "normalizedText": "Received growth factor support to maintain bone marrow function",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 95
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0096",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening",
      "normalizedText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 1000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 1000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1b1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 96
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0097",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening",
      "normalizedText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number < 1000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number < 1000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1b2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 97
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1b2a"
    },
    {
      "atomicId": "A0098",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
      "normalizedText": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number >= 80"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1b2b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 98
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b2b"
    },
    {
      "atomicId": "A0099",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Platelets >= 75,000/mm3 at Screening",
      "normalizedText": "Platelets >= 75,000/mm3 at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 75000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 75000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1c1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 99
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1c1"
    },
    {
      "atomicId": "A0100",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Received platelet transfusion",
      "normalizedText": "Received platelet transfusion",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1c2a1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 100
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1c2a1"
    },
    {
      "atomicId": "A0101",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Hemoglobin >= 9.0 g/dL at Screening",
      "normalizedText": "Hemoglobin >= 9.0 g/dL at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3000963
        ],
        "conceptNames": [
          "Hemoglobin [Mass/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "718-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 9.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 9.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|718-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_1d",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 101
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1d"
    },
    {
      "atomicId": "A0102",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Serum creatinine <= 2.0 mg/dL at Screening",
      "normalizedText": "Serum creatinine <= 2.0 mg/dL at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "2160-0"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 2.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 2.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 102
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0103",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Calculated creatinine clearance >= 50 mL/min at Screening",
      "normalizedText": "Calculated creatinine clearance >= 50 mL/min at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "2160-0"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number >= 50",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 50"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 103
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0104",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "AST <= 3.0 x ULN at Screening",
      "normalizedText": "AST <= 3.0 x ULN at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013721
        ],
        "conceptNames": [
          "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1920-8"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1920-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_3a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 104
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3a"
    },
    {
      "atomicId": "A0105",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "ALT <= 3.0 x ULN at Screening",
      "normalizedText": "ALT <= 3.0 x ULN at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3006923
        ],
        "conceptNames": [
          "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1742-6"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1742-6",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_3b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 105
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3b"
    },
    {
      "atomicId": "A0106",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Bilirubin <= 1.5 x ULN at Screening",
      "normalizedText": "Bilirubin <= 1.5 x ULN at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1975-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 1.5",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.5"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_3c1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 106
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "3c1"
    },
    {
      "atomicId": "A0107",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "Subject has diagnosis of Gilbert's Syndrome",
      "normalizedText": "Subject has diagnosis of Gilbert's Syndrome",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4099740
        ],
        "conceptNames": [
          "Gilbert's syndrome"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "27503000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "27503000",
            "display": "Gilbert's syndrome"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E80.4",
            "display": "Gilbert syndrome"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_3c2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 107
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "3c2"
    },
    {
      "atomicId": "A0108",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "aPTT must not exceed 1.2 x ULN at Screening",
      "normalizedText": "aPTT must not exceed 1.2 x ULN at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013466
        ],
        "conceptNames": [
          "aPTT in Blood by Coagulation assay"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "3173-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value_as_number <= 1.2",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.2"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "3173-2",
            "display": "aPTT in Blood by Coagulation assay"
          }
        ],
        "searchParams": "code=http://loinc.org|3173-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_4a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 108
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4a"
    },
    {
      "atomicId": "A0109",
      "originalCriterionId": "INC_5.2.3.6",
      "criterionType": "inclusion",
      "atomicText": "PT must not exceed 1.2 x ULN at Screening",
      "normalizedText": "PT must not exceed 1.2 x ULN at Screening",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 30.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3034426
        ],
        "conceptNames": [
          "Prothrombin time (PT)"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "5902-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value_as_number <= 1.2",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 1.2"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "5902-2",
            "display": "Prothrombin time (PT)"
          }
        ],
        "searchParams": "code=http://loinc.org|5902-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.6_4b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 109
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "6. The subject must have adequate bone marrow independent of growth factor support \n(with the exception of subjects with ANC < 1000/\uf06dL and bone marrow heavily\ninfiltrated with underlying disease [80% or more]), renal and hepatic function, per \nlocal laboratory reference range at Screening as follows:\n\u25cf Bone marrow: Absolute Neutrophil count (ANC) \u2265 1000/\uf06dL; \nPlatelets \u2265 75,000/mm3\n(entry platelet count must be independent of \ntransfusion within 14 days of Screening); Hemoglobin \u2265 9.0 g/dL;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4b"
    },
    {
      "atomicId": "A0110",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Female sex",
      "normalizedText": "Female sex",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female sex\n-- Requires manual SQL generation",
        "sqlExecutable": false,
        "valueConstraint": "Female"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_0",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 110
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "0"
    },
    {
      "atomicId": "A0111",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile",
      "normalizedText": "Surgically sterile",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 111
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0112",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Postmenopausal for at least 1 year",
      "normalizedText": "Postmenopausal for at least 1 year",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number >= 1"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 112
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0113",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Positive serum pregnancy test at Screening",
      "normalizedText": "Positive serum pregnancy test at Screening",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive",
        "sqlExecutable": true,
        "valueConstraint": "Positive"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_3a1a",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 113
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "pregnancy_test",
      "expressionNodeId": "3a1a"
    },
    {
      "atomicId": "A0114",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
      "normalizedText": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND value_as_number > 7",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number > 7"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_3b_cond",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 114
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "expressionNodeId": "3b_cond"
    },
    {
      "atomicId": "A0115",
      "originalCriterionId": "INC_5.2.3.7",
      "criterionType": "inclusion",
      "atomicText": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
      "normalizedText": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957 AND Positive",
        "sqlExecutable": true,
        "valueConstraint": "Positive"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.7_3b_req1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 115
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "\u25cf Coagulation: aPTT, PT must not exceed 1.2 \uf0b4 ULN.\n7. Female subjects must be surgically sterile, postmenopausal (for at least 1 year), or \nhave negative results for a pregnancy test performed as follows:\n\u25cf At Screening on a serum sample obtained within 14 days prior to initial study\ndrug administration, and\n\u25cf Prior to dosing on a urine sample obtained on Lead-in Day 1 if it has been \n> 7 days since obtaining the serum pregnancy test results.",
        "confidence": 1.0
      },
      "queryableStatus": "screening_only",
      "nonQueryableReason": "Stage 2 classified as screening_only: site/documentation requirement, not a patient filter",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "screening_only",
      "clinicalConceptGroup": "pregnancy_test",
      "expressionNodeId": "3b_req1"
    },
    {
      "atomicId": "A0116",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Female",
      "normalizedText": "Female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_c1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 116
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "c1a"
    },
    {
      "atomicId": "A0117",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Surgically sterile",
      "normalizedText": "Surgically sterile",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_c1b1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 117
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "female_not_childbearing_potential",
      "expressionNodeId": "c1b1"
    },
    {
      "atomicId": "A0118",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Postmenopausal for at least 1 year",
      "normalizedText": "Postmenopausal for at least 1 year",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_c1b2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 118
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "female_not_childbearing_potential",
      "expressionNodeId": "c1b2"
    },
    {
      "atomicId": "A0119",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Male",
      "normalizedText": "Male",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Male\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_c2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 119
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "c2a"
    },
    {
      "atomicId": "A0120",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "History of vasectomy",
      "normalizedText": "History of vasectomy",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_c2b1",
        "groupLogic": "NOT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 120
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queyrable",
      "expressionNodeId": "c2b1"
    },
    {
      "atomicId": "A0121",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle",
      "normalizedText": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT p.person_id\nFROM person p\nWHERE p.gender_concept_id = 8507  -- MALE",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_r1",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 121
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "contraception_method",
      "expressionNodeId": "r1"
    },
    {
      "atomicId": "A0122",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Partner is vasectomized",
      "normalizedText": "Partner is vasectomized",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_r2",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 122
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "contraception_method",
      "expressionNodeId": "r2"
    },
    {
      "atomicId": "A0123",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
      "normalizedText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600058216
        ],
        "conceptNames": [
          "Other Investigational Agent"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C156875"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600058216)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C156875",
            "display": "Other Investigational Agent"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C156875",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_r3",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 123
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "contraception_method",
      "expressionNodeId": "r3"
    },
    {
      "atomicId": "A0124",
      "originalCriterionId": "INC_5.2.3.8",
      "criterionType": "inclusion",
      "atomicText": "Practices double-barrier method of birth control",
      "normalizedText": "Practices double-barrier method of birth control",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.8_r4",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 124
      },
      "provenance": {
        "pageNumber": 32,
        "textSnippet": "> 7 days since obtaining the serum pregnancy test results.\n8. All female subjects not surgically sterile or postmenopausal (for at least 1 year) and \nnon-vasectomized male subjects must practice at least one of the following \nmethods of birth control:\n\u25cf total abstinence from sexual intercourse (minimum one complete menstrual \ncycle);\n\u25cf a vasectomized partner;\n\u25cf hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months \nprior to study drug administration;",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "contraception_method",
      "expressionNodeId": "r4"
    },
    {
      "atomicId": "A0125",
      "originalCriterionId": "INC_5.2.3.9",
      "criterionType": "inclusion",
      "atomicText": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
      "normalizedText": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.3.9_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 125
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "9. The subject must voluntarily sign and date an informed consent, approved by an \nIndependent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to \nthe initiation of any screening or study-specific procedures.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0126",
      "originalCriterionId": "EXC_5.2.4.1",
      "criterionType": "exclusion",
      "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
      "normalizedText": "History of cancer-related Central Nervous System (CNS) disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          600055953
        ],
        "conceptNames": [
          "Prior Invasive Malignancy"
        ],
        "vocabularyIds": [
          "NCIt_Full"
        ],
        "conceptCodes": [
          "C154619"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id IN (600055953)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "code": "C154619",
            "display": "Prior Invasive Malignancy"
          }
        ],
        "searchParams": "code=http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl|C154619",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.1_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 126
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "5.2.4 Phase 2a Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "cns_disease_presence",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0127",
      "originalCriterionId": "EXC_5.2.4.1",
      "criterionType": "exclusion",
      "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
      "normalizedText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.1_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 127
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "5.2.4 Phase 2a Exclusion Criteria\nA subject will not be eligible for study participation if he/she meets any of the following \ncriteria:\n1. The subject has a history or is clinically suspicious for cancer-related Central \nNervous System (CNS) disease.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "cns_disease_presence",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0128",
      "originalCriterionId": "EXC_5.2.4.2",
      "criterionType": "exclusion",
      "atomicText": "History of an underlying, predisposing condition of bleeding",
      "normalizedText": "History of an underlying, predisposing condition of bleeding",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.2_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 128
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "Nervous System (CNS) disease.\n2. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "bleeding_risk",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0129",
      "originalCriterionId": "EXC_5.2.4.2",
      "criterionType": "exclusion",
      "atomicText": "Currently exhibits signs of bleeding",
      "normalizedText": "Currently exhibits signs of bleeding",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.2_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 129
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "Nervous System (CNS) disease.\n2. The subject has a recent history (within 1 year prior to first dose of study drug) of \nan underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "bleeding_risk",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0130",
      "originalCriterionId": "EXC_5.2.4.3",
      "criterionType": "exclusion",
      "atomicText": "Undergone an allogeneic stem cell transplant",
      "normalizedText": "Undergone an allogeneic stem cell transplant",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4028623
        ],
        "conceptNames": [
          "Transplantation of bone marrow"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "23719005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "23719005",
            "display": "Transplantation of bone marrow"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|23719005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.3_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 130
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n3. The subject has undergone an allogeneic or autologous stem cell transplant.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "stem_cell_transplant",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0131",
      "originalCriterionId": "EXC_5.2.4.3",
      "criterionType": "exclusion",
      "atomicText": "Undergone an autologous stem cell transplant",
      "normalizedText": "Undergone an autologous stem cell transplant",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4028623
        ],
        "conceptNames": [
          "Transplantation of bone marrow"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "23719005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4028623)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "23719005",
            "display": "Transplantation of bone marrow"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|23719005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.3_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 131
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "an underlying, predisposing condition of bleeding or currently exhibits signs of \nbleeding.\n3. The subject has undergone an allogeneic or autologous stem cell transplant.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "stem_cell_transplant",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0132",
      "originalCriterionId": "EXC_5.2.4.4",
      "criterionType": "exclusion",
      "atomicText": "Active peptic ulcer disease",
      "normalizedText": "Active peptic ulcer disease",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.4_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 132
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "gi_hemorrhagic_risk",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0133",
      "originalCriterionId": "EXC_5.2.4.4",
      "criterionType": "exclusion",
      "atomicText": "Potentially hemorrhagic esophagitis",
      "normalizedText": "Potentially hemorrhagic esophagitis",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.4_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 133
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "gi_hemorrhagic_risk",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0134",
      "originalCriterionId": "EXC_5.2.4.4",
      "criterionType": "exclusion",
      "atomicText": "Potentially hemorrhagic gastritis",
      "normalizedText": "Potentially hemorrhagic gastritis",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.4_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 134
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "3. The subject has undergone an allogeneic or autologous stem cell transplant.\n4. The subject has active peptic ulcer disease or other potentially hemorrhagic \nesophagitis/gastritis.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "gi_hemorrhagic_risk",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0135",
      "originalCriterionId": "EXC_5.2.4.5",
      "criterionType": "exclusion",
      "atomicText": "Active immune thrombocytopenic purpura",
      "normalizedText": "Active immune thrombocytopenic purpura",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.5_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 135
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "esophagitis/gastritis.\n5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study\ndrug).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0136",
      "originalCriterionId": "EXC_5.2.4.5",
      "criterionType": "exclusion",
      "atomicText": "History of being refractory to platelet transfusions",
      "normalizedText": "History of being refractory to platelet transfusions",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.5_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 136
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "esophagitis/gastritis.\n5. The subject has active immune thrombocytopenic purpura or a history of being \nrefractory to platelet transfusions (within 1 year prior to the first dose of study\ndrug).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0137",
      "originalCriterionId": "EXC_5.2.4.6",
      "criterionType": "exclusion",
      "atomicText": "Currently receiving or requires anticoagulation therapy",
      "normalizedText": "Currently receiving or requires anticoagulation therapy",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.6_1a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 137
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0138",
      "originalCriterionId": "EXC_5.2.4.6",
      "criterionType": "exclusion",
      "atomicText": "Receiving drugs or herbal supplements that affect platelet function",
      "normalizedText": "Receiving drugs or herbal supplements that affect platelet function",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.6_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 138
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0139",
      "originalCriterionId": "EXC_5.2.4.6",
      "criterionType": "exclusion",
      "atomicText": "Receiving low-dose anticoagulation for central intravenous catheter patency",
      "normalizedText": "Receiving low-dose anticoagulation for central intravenous catheter patency",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "low-dose AND for catheter patency"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.6_2",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 139
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "drug).\n6. The subject is currently receiving or requires anticoagulation therapy or any drugs \nor herbal supplements that affect platelet function, with the exception of low-dose \nanticoagulation medications that are used to maintain the patency of a central \nintravenous catheter.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0140",
      "originalCriterionId": "EXC_5.2.4.7",
      "criterionType": "exclusion",
      "atomicText": "Received steroid therapy for anti-neoplastic intent",
      "normalizedText": "Received steroid therapy for anti-neoplastic intent",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.7_1a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 140
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0141",
      "originalCriterionId": "EXC_5.2.4.7",
      "criterionType": "exclusion",
      "atomicText": "Received inhaled steroids for asthma",
      "normalizedText": "Received inhaled steroids for asthma",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.7_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 141
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0142",
      "originalCriterionId": "EXC_5.2.4.7",
      "criterionType": "exclusion",
      "atomicText": "Received topical steroids",
      "normalizedText": "Received topical steroids",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.7_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 142
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0143",
      "originalCriterionId": "EXC_5.2.4.7",
      "criterionType": "exclusion",
      "atomicText": "Received replacement/stress corticosteroids",
      "normalizedText": "Received replacement/stress corticosteroids",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          1243048
        ],
        "conceptNames": [
          "Systemic corticosteroid therapy"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "1290388005"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (1243048)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "MedicationStatement",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "1290388005",
            "display": "Systemic corticosteroid therapy"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|1290388005",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.7_2c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 143
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "intravenous catheter.\n7. The subject has received steroid therapy for anti-neoplastic intent within 7 days \nprior to the first dose of study drug with the exception of inhaled steroids for \nasthma, topical steroids or replacement/stress corticosteroids.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2c"
    },
    {
      "atomicId": "A0144",
      "originalCriterionId": "EXC_5.2.4.8",
      "criterionType": "exclusion",
      "atomicText": "Received aspirin",
      "normalizedText": "Received aspirin",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND de.drug_exposure_start_date >= @reference_date - INTERVAL '7 days'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.8_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 144
      },
      "provenance": {
        "pageNumber": 33,
        "textSnippet": "asthma, topical steroids or replacement/stress corticosteroids.\n8. The subject has received aspirin within 7 days prior to the first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0145",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received chemotherapy",
      "normalizedText": "Received chemotherapy",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 50.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 145
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0146",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received immunotherapy",
      "normalizedText": "Received immunotherapy",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 146
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0147",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received radiotherapy",
      "normalizedText": "Received radiotherapy",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 147
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a3"
    },
    {
      "atomicId": "A0148",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received hormonal anti-cancer therapy",
      "normalizedText": "Received hormonal anti-cancer therapy",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a4a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 148
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "anti_cancer_therapy",
      "expressionNodeId": "1a4a"
    },
    {
      "atomicId": "A0149",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received hormones for thyroid conditions",
      "normalizedText": "Received hormones for thyroid conditions",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a4b1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 149
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a4b1"
    },
    {
      "atomicId": "A0150",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received estrogen replacement therapy (ERT)",
      "normalizedText": "Received estrogen replacement therapy (ERT)",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a4b2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 150
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a4b2"
    },
    {
      "atomicId": "A0151",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Received any investigational therapy",
      "normalizedText": "Received any investigational therapy",
      "category": "prior_therapy",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_1a5",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 151
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a5"
    },
    {
      "atomicId": "A0152",
      "originalCriterionId": "EXC_5.2.4.9",
      "criterionType": "exclusion",
      "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
      "normalizedText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "value_as_number < 2"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.9_2a",
        "groupLogic": "NOT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 152
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "9. The subject has received any anti-cancer therapy including chemotherapy, \nimmunotherapy, radiotherapy, hormonal (with the exception of hormones for \nthyroid conditions or estrogen replacement therapy [ERT]), or any investigational \ntherapy within 14 days prior to the first dose of study drug, or has not recovered to \nless than grade 2 clinically significant adverse effect(s)/toxicity(ies) of the previous \ntherapy.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0153",
      "originalCriterionId": "EXC_5.2.4.10",
      "criterionType": "exclusion",
      "atomicText": "Received a biologic agent",
      "normalizedText": "Received a biologic agent",
      "category": "treatment_history",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.10_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 153
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "therapy.\n10. The subject has received a biologic within 30 days prior to the first dose of study\ndrug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "prior_therapy",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0154",
      "originalCriterionId": "EXC_5.2.4.11",
      "criterionType": "exclusion",
      "atomicText": "Consumed grapefruit",
      "normalizedText": "Consumed grapefruit",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.11_1a1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 154
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "grapefruit_consumption",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0155",
      "originalCriterionId": "EXC_5.2.4.11",
      "criterionType": "exclusion",
      "atomicText": "Consumed grapefruit products",
      "normalizedText": "Consumed grapefruit products",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.11_1a2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 155
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "drug.\n11. The subject has consumed grapefruit or grapefruit products within 3 days prior to \nthe first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "grapefruit_consumption",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0156",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Myocardial infarction",
      "normalizedText": "Myocardial infarction",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1a_op_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 156
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "significant_cardiovascular_disease",
      "expressionNodeId": "1a_op_1"
    },
    {
      "atomicId": "A0157",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Thrombotic event",
      "normalizedText": "Thrombotic event",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1a_op_2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 157
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "significant_cardiovascular_disease",
      "expressionNodeId": "1a_op_2"
    },
    {
      "atomicId": "A0158",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Thromboembolic event",
      "normalizedText": "Thromboembolic event",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1a_op_3",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 158
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "significant_cardiovascular_disease",
      "expressionNodeId": "1a_op_3"
    },
    {
      "atomicId": "A0159",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of cardiovascular disease",
      "normalizedText": "Significant history of cardiovascular disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 159
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "significant_cardiovascular_disease",
      "expressionNodeId": "1b"
    },
    {
      "atomicId": "A0160",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of renal disease",
      "normalizedText": "Significant history of renal disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1c",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 160
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1c"
    },
    {
      "atomicId": "A0161",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of neurologic disease",
      "normalizedText": "Significant history of neurologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1d",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 161
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1d"
    },
    {
      "atomicId": "A0162",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of psychiatric disease",
      "normalizedText": "Significant history of psychiatric disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1e",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 162
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1e"
    },
    {
      "atomicId": "A0163",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of endocrinologic disease",
      "normalizedText": "Significant history of endocrinologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1f",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 163
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1f"
    },
    {
      "atomicId": "A0164",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of metabolic disease",
      "normalizedText": "Significant history of metabolic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1g",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 164
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1g"
    },
    {
      "atomicId": "A0165",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of immunologic disease",
      "normalizedText": "Significant history of immunologic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1h",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 165
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1h"
    },
    {
      "atomicId": "A0166",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Significant history of hepatic disease",
      "normalizedText": "Significant history of hepatic disease",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_1i",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 166
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1i"
    },
    {
      "atomicId": "A0167",
      "originalCriterionId": "EXC_5.2.4.12",
      "criterionType": "exclusion",
      "atomicText": "Disease history would adversely affect participation in the study in the opinion of the investigator",
      "normalizedText": "Disease history would adversely affect participation in the study in the opinion of the investigator",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.25,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.12_2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 167
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "the first dose of study drug.\n12. The subject has a significant history of cardiovascular disease (e.g., myocardial \ninfarction [MI], thrombotic, or thromboembolic event in the last 6 months), renal, \nneurologic, psychiatric, endocrinologic, metabolic, immunologic, or hepatic \ndisease that in the opinion of the investigator would adversely affect his/her \nparticipating in this study.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0168",
      "originalCriterionId": "EXC_5.2.4.13",
      "criterionType": "exclusion",
      "atomicText": "Subject is female",
      "normalizedText": "Subject is female",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "person",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "-- Unknown table: person\n-- Atomic text: Subject is female\n-- Requires manual SQL generation",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.13_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 168
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0169",
      "originalCriterionId": "EXC_5.2.4.13",
      "criterionType": "exclusion",
      "atomicText": "Subject is pregnant",
      "normalizedText": "Subject is pregnant",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [
          42528957
        ],
        "conceptNames": [
          "Pregnancy status"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "82810-3"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM observation WHERE observation_concept_id = 42528957",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "82810-3",
            "display": "Pregnancy status"
          },
          {
            "system": "http://snomed.info/sct",
            "code": "77386006",
            "display": "Pregnancy"
          }
        ],
        "searchParams": "code=http://loinc.org|82810-3,77386006",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.13_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 169
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "pregnancy_lactation_status",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0170",
      "originalCriterionId": "EXC_5.2.4.13",
      "criterionType": "exclusion",
      "atomicText": "Subject is breast-feeding",
      "normalizedText": "Subject is breast-feeding",
      "category": "demographics",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.13_2b",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 170
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "participating in this study.\n13. A female subject is pregnant or breast-feeding.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "demographics",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "pregnancy_lactation_status",
      "expressionNodeId": "2b"
    },
    {
      "atomicId": "A0171",
      "originalCriterionId": "EXC_5.2.4.14",
      "criterionType": "exclusion",
      "atomicText": "Tested positive for HIV",
      "normalizedText": "Tested positive for HIV",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          439727
        ],
        "conceptNames": [
          "Human immunodeficiency virus infection"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "86406008"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (439727)",
        "sqlExecutable": true,
        "valueConstraint": "Positive"
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "86406008",
            "display": "Human immunodeficiency virus infection"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B20",
            "display": "Human immunodeficiency virus [HIV] disease"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|86406008,B20",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.14_1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 171
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "14. The subject has tested positive for HIV (due to potential drug-drug interactions \nbetween anti-retroviral medications and ABT-263, as well as anticipated ABT-263 \nmechanism based lymphopenia that may potentially increase the risk of \nopportunistic infections and potential drug-drug interactions with certain \nanti-infective agents).",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0172",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "History of other active malignancy",
      "normalizedText": "History of other active malignancy",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)\n  AND co.condition_start_date >= @reference_date - INTERVAL '3 years'",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_1a",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 172
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0173",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Adequately treated in situ carcinoma of the cervix uteri",
      "normalizedText": "Adequately treated in situ carcinoma of the cervix uteri",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2a",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 173
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0174",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Basal cell carcinoma of the skin",
      "normalizedText": "Basal cell carcinoma of the skin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2b1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 174
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "non_melanoma_skin_cancer",
      "expressionNodeId": "2b1"
    },
    {
      "atomicId": "A0175",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Squamous cell carcinoma of the skin",
      "normalizedText": "Squamous cell carcinoma of the skin",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2b2",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 175
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "non_melanoma_skin_cancer",
      "expressionNodeId": "2b2"
    },
    {
      "atomicId": "A0176",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Previous malignancy confined",
      "normalizedText": "Previous malignancy confined",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2c1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 176
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2c1"
    },
    {
      "atomicId": "A0177",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Previous malignancy surgically resected",
      "normalizedText": "Previous malignancy surgically resected",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT po.person_id\nFROM procedure_occurrence po\nWHERE po.procedure_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2c2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 177
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2c2"
    },
    {
      "atomicId": "A0178",
      "originalCriterionId": "EXC_5.2.4.15",
      "criterionType": "exclusion",
      "atomicText": "Surgical resection was with curative intent",
      "normalizedText": "Surgical resection was with curative intent",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "procedure_occurrence",
        "conceptIds": [
          4301351
        ],
        "conceptNames": [
          "Surgical procedure"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "387713003"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM procedure_occurrence WHERE procedure_concept_id IN (4301351)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Procedure",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "387713003",
            "display": "Surgical procedure"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|387713003",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.15_2c3",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 178
      },
      "provenance": {
        "pageNumber": 34,
        "textSnippet": "anti-infective agents).\n15. The subject has a history of other active malignancies within the past 3 years prior \nto study entry, with the exception of:\n\u25cf adequately treated in situ carcinoma of the cervix uteri;\n\u25cf basal or squamous cell carcinoma of the skin;\n\u25cf previous malignancy confined and surgically resected with curative intent.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2c3"
    },
    {
      "atomicId": "A0179",
      "originalCriterionId": "EXC_5.2.4.16",
      "criterionType": "exclusion",
      "atomicText": "Uncontrolled systemic infection (viral, bacterial, or fungal)",
      "normalizedText": "Uncontrolled systemic infection (viral, bacterial, or fungal)",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4329847
        ],
        "conceptNames": [
          "Myocardial infarction"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "22298006"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4329847)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "22298006",
            "display": "Myocardial infarction"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I21.9",
            "display": "Acute myocardial infarction, unspecified"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|22298006,I21.9",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.16_1",
        "groupLogic": "OR",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 179
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "partially_queryable",
      "clinicalConceptGroup": "uncontrolled_conditions",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0180",
      "originalCriterionId": "EXC_5.2.4.16",
      "criterionType": "exclusion",
      "atomicText": "Diagnosis of fever",
      "normalizedText": "Diagnosis of fever",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.16_2a1",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 180
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "febrile_neutropenia",
      "expressionNodeId": "2a1"
    },
    {
      "atomicId": "A0181",
      "originalCriterionId": "EXC_5.2.4.16",
      "criterionType": "exclusion",
      "atomicText": "Diagnosis of neutropenia",
      "normalizedText": "Diagnosis of neutropenia",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT co.person_id\nFROM condition_occurrence co\nWHERE co.condition_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.16_2a2",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 181
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "16. The subject exhibits evidence of other clinically significant uncontrolled \ncondition(s) including, but not limited to:\n\u25cf uncontrolled systemic infection (viral, bacterial, or fungal);\n\u25cf diagnosis of fever and neutropenia within one week prior to study drug \nadministration.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "febrile_neutropenia",
      "expressionNodeId": "2a2"
    },
    {
      "atomicId": "A0182",
      "originalCriterionId": "EXC_5.2.4.17",
      "criterionType": "exclusion",
      "atomicText": "Received known CYP3A inhibitors",
      "normalizedText": "Received known CYP3A inhibitors",
      "category": "safety_exclusion",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "drug_exposure",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT de.person_id\nFROM drug_exposure de\nWHERE de.drug_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "e.g., ketoconazole"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_EXC_5.2.4.17_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "NOT",
        "isExclusion": true,
        "sequenceHint": 182
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "administration.\n17. The subject has received known CYP3A inhibitors (e.g., ketoconazole) within\n7 days prior to first dose of study drug.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "safety_exclusion",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "cyp3a_inhibitors",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0183",
      "originalCriterionId": "INC_5.2.5.1",
      "criterionType": "inclusion",
      "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 1",
      "normalizedText": "Meets all Inclusion and Exclusion criteria from Phase 1",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.1_1a1",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 183
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a1"
    },
    {
      "atomicId": "A0184",
      "originalCriterionId": "INC_5.2.5.1",
      "criterionType": "inclusion",
      "atomicText": "Laboratory parameters from Phase 1",
      "normalizedText": "Laboratory parameters from Phase 1",
      "category": "organ_function",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.1_1a2",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 184
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1a2"
    },
    {
      "atomicId": "A0185",
      "originalCriterionId": "INC_5.2.5.1",
      "criterionType": "inclusion",
      "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 2a",
      "normalizedText": "Meets all Inclusion and Exclusion criteria from Phase 2a",
      "category": "diagnostic_confirmation",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "observation",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT o.person_id\nFROM observation o\nWHERE o.observation_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.1_1b1",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 185
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "diagnostic_confirmation",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b1"
    },
    {
      "atomicId": "A0186",
      "originalCriterionId": "INC_5.2.5.1",
      "criterionType": "inclusion",
      "atomicText": "Laboratory parameters from Phase 2a",
      "normalizedText": "Laboratory parameters from Phase 2a",
      "category": "organ_function",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.1_1b2",
        "groupLogic": "EXCEPT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 186
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b2"
    },
    {
      "atomicId": "A0187",
      "originalCriterionId": "INC_5.2.5.1",
      "criterionType": "inclusion",
      "atomicText": "Stable lab values per applicable laboratory reference ranges",
      "normalizedText": "Stable lab values per applicable laboratory reference ranges",
      "category": "organ_function",
      "funnelImpact": {
        "eliminationRate": 0.0,
        "impactScore": 0.0,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.1_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 187
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "5.2.5 Extension Study Inclusion Criteria\nSubjects who enter the Extension Study must continue to meet all Inclusion and Exclusion \ncriteria (excluding laboratory parameters) from Phase 1 or in Phase 2a as listed above. \nSubjects entering the Extension Study must also have stable lab values per applicable \nlaboratory reference ranges.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0188",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Platelet count >= 25,000/mm3 (untransfused)",
      "normalizedText": "Platelet count >= 25,000/mm3 (untransfused)",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number >= 25000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 25000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_1a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 188
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1a"
    },
    {
      "atomicId": "A0189",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Platelet count <= 50,000/mm3",
      "normalizedText": "Platelet count <= 50,000/mm3",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461 AND value_as_number <= 50000",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 50000"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_1b_cond",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 189
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "1b_cond"
    },
    {
      "atomicId": "A0190",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Platelet count is stable",
      "normalizedText": "Platelet count is stable",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_1b_req1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 190
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b_req1"
    },
    {
      "atomicId": "A0191",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Platelet count is monitored at an increased frequency at the discretion of the investigator",
      "normalizedText": "Platelet count is monitored at an increased frequency at the discretion of the investigator",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3007461
        ],
        "conceptNames": [
          "Platelets [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26515-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3007461",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26515-7",
            "display": "Platelets [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26515-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_1b_req2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 191
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "1b_req2"
    },
    {
      "atomicId": "A0192",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) >= 500/uL",
      "normalizedText": "Absolute Neutrophil count (ANC) >= 500/uL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 500"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_2a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 192
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2a"
    },
    {
      "atomicId": "A0193",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL",
      "normalizedText": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732 AND value_as_number >= 500 AND value_as_number <= 999.99",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 500 AND value_as_number <= 999.99"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_2b_cond",
        "groupLogic": "IMPLICATION_CONDITION",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 193
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2b_cond"
    },
    {
      "atomicId": "A0194",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "ANC is monitored at an increased frequency at the discretion of the investigator",
      "normalizedText": "ANC is monitored at an increased frequency at the discretion of the investigator",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3017732
        ],
        "conceptNames": [
          "Neutrophils [#/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "26499-4"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3017732",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "26499-4",
            "display": "Neutrophils [#/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|26499-4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_2b_req",
        "groupLogic": "IMPLICATION_REQUIREMENT",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 194
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "expressionNodeId": "2b_req"
    },
    {
      "atomicId": "A0195",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "Hemoglobin >= 8.0 g/dL",
      "normalizedText": "Hemoglobin >= 8.0 g/dL",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3000963
        ],
        "conceptNames": [
          "Hemoglobin [Mass/volume] in Blood"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "718-7"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3000963 AND value_as_number >= 8.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number >= 8.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood"
          }
        ],
        "searchParams": "code=http://loinc.org|718-7",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_3",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 195
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "3"
    },
    {
      "atomicId": "A0196",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "aPTT not to exceed 1.2 x ULN",
      "normalizedText": "aPTT not to exceed 1.2 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013466
        ],
        "conceptNames": [
          "aPTT in Blood by Coagulation assay"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "3173-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013466 AND value <= 1.2 * Upper Limit of Normal",
        "sqlExecutable": true,
        "valueConstraint": "value <= 1.2 * Upper Limit of Normal"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "3173-2",
            "display": "aPTT in Blood by Coagulation assay"
          }
        ],
        "searchParams": "code=http://loinc.org|3173-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_4a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 196
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4a"
    },
    {
      "atomicId": "A0197",
      "originalCriterionId": "INC_5.2.5.2",
      "criterionType": "inclusion",
      "atomicText": "PT not to exceed 1.2 x ULN",
      "normalizedText": "PT not to exceed 1.2 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 25.0,
        "impactScore": 0.8,
        "isKillerCriterion": true
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3034426
        ],
        "conceptNames": [
          "Prothrombin time (PT)"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "5902-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id IN (3034426) AND value <= 1.2 * Upper Limit of Normal",
        "sqlExecutable": true,
        "valueConstraint": "value <= 1.2 * Upper Limit of Normal"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "5902-2",
            "display": "Prothrombin time (PT)"
          }
        ],
        "searchParams": "code=http://loinc.org|5902-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.2_4b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 197
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "laboratory reference ranges.\n\u25cf Subjects must meet the following hematology and coagulation lab criteria:\n\u25cb Platelet counts must be \u2265 25,000/mm3\n(untransfused). Platelet counts \n\uf0a3 50,000/mm3 must be stable and monitored at an increased frequency at \nthe discretion of the investigator.\n\u25cb Absolute Neutrophil count (ANC) \u2265 500/\uf06dL. ANC \u2265 500/\u00b5L and \n< 1,000/\u00b5L should be monitored at an increased frequency at the discretion \nof the investigator.\n\u25cb Hemoglobin of \u2265 8.0 g/dL.\n\u25cb aPTT, PT is not to exce...",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "4b"
    },
    {
      "atomicId": "A0198",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "Chemistry values do not exceed Grade 2",
      "normalizedText": "Chemistry values do not exceed Grade 2",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [],
        "conceptNames": [],
        "vocabularyIds": [],
        "conceptCodes": [],
        "sqlTemplate": "SELECT DISTINCT m.person_id\nFROM measurement m\nWHERE m.measurement_concept_id IN (/* UNMAPPED - requires manual concept selection */)",
        "sqlExecutable": false,
        "valueConstraint": "values must be <= Grade 2 per CTCAE"
      },
      "fhirQuery": null,
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 198
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "partially_queryable",
      "expressionNodeId": "1"
    },
    {
      "atomicId": "A0199",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "Serum creatinine <= 3.0 x ULN",
      "normalizedText": "Serum creatinine <= 3.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3016723
        ],
        "conceptNames": [
          "Creatinine [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "2160-0"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3016723 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|2160-0",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 199
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "2"
    },
    {
      "atomicId": "A0200",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "AST <= 5.0 x ULN",
      "normalizedText": "AST <= 5.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3013721
        ],
        "conceptNames": [
          "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1920-8"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3013721 AND value_as_number <= 5.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 5.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1920-8",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_3a",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 200
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "liver_function_tests",
      "expressionNodeId": "3a"
    },
    {
      "atomicId": "A0201",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "ALT <= 5.0 x ULN",
      "normalizedText": "ALT <= 5.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3006923
        ],
        "conceptNames": [
          "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1742-6"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3006923 AND value_as_number <= 5.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 5.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1742-6",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_3b",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 201
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "liver_function_tests",
      "expressionNodeId": "3b"
    },
    {
      "atomicId": "A0202",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "Bilirubin <= 3.0 x ULN",
      "normalizedText": "Bilirubin <= 3.0 x ULN",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1975-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128 AND value_as_number <= 3.0",
        "sqlExecutable": true,
        "valueConstraint": "value_as_number <= 3.0"
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_4a",
        "groupLogic": "OR",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 202
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "fully_queryable",
      "clinicalConceptGroup": "bilirubin_level",
      "expressionNodeId": "4a"
    },
    {
      "atomicId": "A0203",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "Subject has Gilbert's Syndrome",
      "normalizedText": "Subject has Gilbert's Syndrome",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "condition_occurrence",
        "conceptIds": [
          4099740
        ],
        "conceptNames": [
          "Gilbert's syndrome"
        ],
        "vocabularyIds": [
          "SNOMED"
        ],
        "conceptCodes": [
          "27503000"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM condition_occurrence WHERE condition_concept_id IN (4099740)",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Condition",
        "codes": [
          {
            "system": "http://snomed.info/sct",
            "code": "27503000",
            "display": "Gilbert's syndrome"
          },
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E80.4",
            "display": "Gilbert syndrome"
          }
        ],
        "searchParams": "code=http://snomed.info/sct|27503000,E80.4",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_4b1",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 203
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "disease_indication",
      "stage2QueryableStatus": "fully_queryable",
      "expressionNodeId": "4b1"
    },
    {
      "atomicId": "A0204",
      "originalCriterionId": "INC_5.2.5.3",
      "criterionType": "inclusion",
      "atomicText": "Bilirubin > 3.0 x ULN approved by investigator and medical monitor",
      "normalizedText": "Bilirubin > 3.0 x ULN approved by investigator and medical monitor",
      "category": "functional",
      "funnelImpact": {
        "eliminationRate": 20.0,
        "impactScore": 0.2,
        "isKillerCriterion": false
      },
      "omopQuery": {
        "tableName": "measurement",
        "conceptIds": [
          3024128
        ],
        "conceptNames": [
          "Bilirubin.total [Mass/volume] in Serum or Plasma"
        ],
        "vocabularyIds": [
          "LOINC"
        ],
        "conceptCodes": [
          "1975-2"
        ],
        "sqlTemplate": "SELECT DISTINCT person_id FROM measurement WHERE measurement_concept_id = 3024128",
        "sqlExecutable": true
      },
      "fhirQuery": {
        "resourceType": "Observation",
        "codes": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma"
          }
        ],
        "searchParams": "code=http://loinc.org|1975-2",
        "queryExecutable": true,
        "valueFilter": null,
        "dateFilter": null
      },
      "executionContext": {
        "logicalGroup": "G_INC_5.2.5.3_4b2",
        "groupLogic": "AND",
        "combineWithPrevious": "AND",
        "isExclusion": false,
        "sequenceHint": 204
      },
      "provenance": {
        "pageNumber": 35,
        "textSnippet": "\u25cb aPTT, PT is not to exceed 1.2 \uf0b4 ULN.\n\u25cf Subjects must meet the following chemistry criteria:\n\u25cb Subjects' chemistry values must not exceed Grade 2. Grade 2 chemistry\nlabs should be monitored at an increased frequency at the discretion of the \ninvestigator.\n\u25cb Serum creatinine \uf0a3 3.0 \uf0b4 the upper normal limit (ULN) of institution's \nnormal range.",
        "confidence": 1.0
      },
      "queryableStatus": "requires_manual",
      "nonQueryableReason": "No OMOP concepts mapped",
      "stage2ClinicalCategory": "organ_function",
      "stage2QueryableStatus": "requires_manual",
      "clinicalConceptGroup": "bilirubin_level",
      "expressionNodeId": "4b2"
    }
  ],
  "logicalGroups": [
    {
      "groupId": "G_INC_5.2.1.2_1",
      "groupLabel": "Criterion INC_5.2.1.2 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0002",
        "A0003"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.2_root",
      "groupLabel": "Criterion INC_5.2.1.2 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0002",
        "A0003",
        "A0004"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.4_1",
      "groupLabel": "Criterion INC_5.2.1.4 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0006",
        "A0007"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_1a2b",
      "groupLabel": "Criterion INC_5.2.1.5 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0010"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_1a4",
      "groupLabel": "Criterion INC_5.2.1.5 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0012"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_1a",
      "groupLabel": "Criterion INC_5.2.1.5 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_1b",
      "groupLabel": "Criterion INC_5.2.1.5 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0013",
        "A0014"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_1",
      "groupLabel": "Criterion INC_5.2.1.5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012",
        "A0013",
        "A0014"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_2",
      "groupLabel": "Criterion INC_5.2.1.5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0015",
        "A0016"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_3c",
      "groupLabel": "Criterion INC_5.2.1.5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0019",
        "A0020"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.5_root",
      "groupLabel": "Criterion INC_5.2.1.5 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0008",
        "A0009",
        "A0010",
        "A0011",
        "A0012",
        "A0013",
        "A0014",
        "A0015",
        "A0016",
        "A0017",
        "A0018",
        "A0019",
        "A0020",
        "A0021",
        "A0022"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_2c1",
      "groupLabel": "Criterion INC_5.2.1.6 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0026"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_2c2_req",
      "groupLabel": "Criterion INC_5.2.1.6 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0028"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_2c2",
      "groupLabel": "Criterion INC_5.2.1.6 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0027",
        "A0028"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_2c",
      "groupLabel": "Criterion INC_5.2.1.6 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0026",
        "A0027",
        "A0028"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_2",
      "groupLabel": "Criterion INC_5.2.1.6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0024",
        "A0025",
        "A0026",
        "A0027",
        "A0028"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.6_root",
      "groupLabel": "Criterion INC_5.2.1.6 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0023",
        "A0024",
        "A0025",
        "A0026",
        "A0027",
        "A0028"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1a2_op",
      "groupLabel": "Criterion INC_5.2.1.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0030",
        "A0031"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1a2",
      "groupLabel": "Criterion INC_5.2.1.7 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0030",
        "A0031"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1a",
      "groupLabel": "Criterion INC_5.2.1.7 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0029",
        "A0030",
        "A0031"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1b2",
      "groupLabel": "Criterion INC_5.2.1.7 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0033"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1b",
      "groupLabel": "Criterion INC_5.2.1.7 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0032",
        "A0033"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_c1",
      "groupLabel": "Criterion INC_5.2.1.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0029",
        "A0030",
        "A0031",
        "A0032",
        "A0033"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_r1",
      "groupLabel": "Criterion INC_5.2.1.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0034",
        "A0035",
        "A0036",
        "A0037"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.7_root",
      "groupLabel": "Criterion INC_5.2.1.7 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0029",
        "A0030",
        "A0031",
        "A0032",
        "A0033",
        "A0034",
        "A0035",
        "A0036",
        "A0037"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.8_3a",
      "groupLabel": "Criterion INC_5.2.1.8 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0040",
        "A0041"
      ]
    },
    {
      "groupId": "G_INC_5.2.1.8_root",
      "groupLabel": "Criterion INC_5.2.1.8 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0038",
        "A0039",
        "A0040",
        "A0041"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.1_root",
      "groupLabel": "Criterion EXC_5.2.2.1 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0042",
        "A0043"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.2_root",
      "groupLabel": "Criterion EXC_5.2.2.2 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0044",
        "A0045"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.3_root",
      "groupLabel": "Criterion EXC_5.2.2.3 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0046",
        "A0047"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.4_root",
      "groupLabel": "Criterion EXC_5.2.2.4 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0048",
        "A0049",
        "A0050"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.5_root",
      "groupLabel": "Criterion EXC_5.2.2.5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0051",
        "A0052"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.7_1",
      "groupLabel": "Criterion EXC_5.2.2.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0054",
        "A0055"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.7_root",
      "groupLabel": "Criterion EXC_5.2.2.7 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0054",
        "A0055",
        "A0056"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.8_2",
      "groupLabel": "Criterion EXC_5.2.2.8 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0058",
        "A0059",
        "A0060"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.8_root",
      "groupLabel": "Criterion EXC_5.2.2.8 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0057",
        "A0058",
        "A0059",
        "A0060"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.9_1a4b",
      "groupLabel": "Criterion EXC_5.2.2.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0065",
        "A0066"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.9_1a4",
      "groupLabel": "Criterion EXC_5.2.2.9 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0064",
        "A0065",
        "A0066"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.9_1a",
      "groupLabel": "Criterion EXC_5.2.2.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065",
        "A0066",
        "A0067"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.9_2",
      "groupLabel": "Criterion EXC_5.2.2.9 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0068"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.9_root",
      "groupLabel": "Criterion EXC_5.2.2.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0065",
        "A0066",
        "A0067",
        "A0068"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.11_1a",
      "groupLabel": "Criterion EXC_5.2.2.11 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0070",
        "A0071"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.12_1b_op",
      "groupLabel": "Criterion EXC_5.2.2.12 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0073",
        "A0074",
        "A0075"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.12_1",
      "groupLabel": "Criterion EXC_5.2.2.12 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0072",
        "A0073",
        "A0074",
        "A0075",
        "A0076",
        "A0077",
        "A0078",
        "A0079",
        "A0080",
        "A0081",
        "A0082"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.12_root",
      "groupLabel": "Criterion EXC_5.2.2.12 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0072",
        "A0073",
        "A0074",
        "A0075",
        "A0076",
        "A0077",
        "A0078",
        "A0079",
        "A0080",
        "A0081",
        "A0082",
        "A0083"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.13_EXC_5.2.2.13_S_or_1",
      "groupLabel": "Criterion EXC_5.2.2.13 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0085",
        "A0086"
      ]
    },
    {
      "groupId": "G_EXC_5.2.2.13_EXC_5.2.2.13_S_and_2",
      "groupLabel": "Criterion EXC_5.2.2.13 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0084",
        "A0085",
        "A0086"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.2_root",
      "groupLabel": "Criterion INC_5.2.3.2 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0088",
        "A0089"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.3_root",
      "groupLabel": "Criterion INC_5.2.3.3 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0090",
        "A0091"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.5_1b1",
      "groupLabel": "Criterion INC_5.2.3.5 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0094"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.5_1",
      "groupLabel": "Criterion INC_5.2.3.5 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0093",
        "A0094"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_1a",
      "groupLabel": "Criterion INC_5.2.3.6 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0095"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_1b2",
      "groupLabel": "Criterion INC_5.2.3.6 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0097",
        "A0098"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_1b",
      "groupLabel": "Criterion INC_5.2.3.6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0096",
        "A0097",
        "A0098"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_1c2",
      "groupLabel": "Criterion INC_5.2.3.6 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0100"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_2",
      "groupLabel": "Criterion INC_5.2.3.6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0102",
        "A0103"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_3c",
      "groupLabel": "Criterion INC_5.2.3.6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0106",
        "A0107"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.6_root",
      "groupLabel": "Criterion INC_5.2.3.6 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0095",
        "A0096",
        "A0097",
        "A0098",
        "A0099",
        "A0100",
        "A0101",
        "A0102",
        "A0103",
        "A0104",
        "A0105",
        "A0106",
        "A0107",
        "A0108",
        "A0109"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_3a",
      "groupLabel": "Criterion INC_5.2.3.7 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0113"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_3b_req",
      "groupLabel": "Criterion INC_5.2.3.7 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0115"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_3b",
      "groupLabel": "Criterion INC_5.2.3.7 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0114",
        "A0115"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_3",
      "groupLabel": "Criterion INC_5.2.3.7 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0113",
        "A0114",
        "A0115"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_main_or",
      "groupLabel": "Criterion INC_5.2.3.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0111",
        "A0112",
        "A0113",
        "A0114",
        "A0115"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.7_root",
      "groupLabel": "Criterion INC_5.2.3.7 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0110",
        "A0111",
        "A0112",
        "A0113",
        "A0114",
        "A0115"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c1b_or",
      "groupLabel": "Criterion INC_5.2.3.8 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0117",
        "A0118"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c1b",
      "groupLabel": "Criterion INC_5.2.3.8 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0117",
        "A0118"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c1",
      "groupLabel": "Criterion INC_5.2.3.8 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0116",
        "A0117",
        "A0118"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c2b",
      "groupLabel": "Criterion INC_5.2.3.8 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0120"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c2",
      "groupLabel": "Criterion INC_5.2.3.8 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0119",
        "A0120"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_c",
      "groupLabel": "Criterion INC_5.2.3.8 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0116",
        "A0117",
        "A0118",
        "A0119",
        "A0120"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_r",
      "groupLabel": "Criterion INC_5.2.3.8 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0121",
        "A0122",
        "A0123",
        "A0124"
      ]
    },
    {
      "groupId": "G_INC_5.2.3.8_root",
      "groupLabel": "Criterion INC_5.2.3.8 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0116",
        "A0117",
        "A0118",
        "A0119",
        "A0120",
        "A0121",
        "A0122",
        "A0123",
        "A0124"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.1_root",
      "groupLabel": "Criterion EXC_5.2.4.1 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0126",
        "A0127"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.2_root",
      "groupLabel": "Criterion EXC_5.2.4.2 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0128",
        "A0129"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.3_root",
      "groupLabel": "Criterion EXC_5.2.4.3 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0130",
        "A0131"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.4_root",
      "groupLabel": "Criterion EXC_5.2.4.4 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0132",
        "A0133",
        "A0134"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.5_root",
      "groupLabel": "Criterion EXC_5.2.4.5 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0135",
        "A0136"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.6_1",
      "groupLabel": "Criterion EXC_5.2.4.6 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0137",
        "A0138"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.6_root",
      "groupLabel": "Criterion EXC_5.2.4.6 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0137",
        "A0138",
        "A0139"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.7_2",
      "groupLabel": "Criterion EXC_5.2.4.7 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0141",
        "A0142",
        "A0143"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.7_root",
      "groupLabel": "Criterion EXC_5.2.4.7 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0140",
        "A0141",
        "A0142",
        "A0143"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.9_1a4b",
      "groupLabel": "Criterion EXC_5.2.4.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0149",
        "A0150"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.9_1a4",
      "groupLabel": "Criterion EXC_5.2.4.9 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0148",
        "A0149",
        "A0150"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.9_1a",
      "groupLabel": "Criterion EXC_5.2.4.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0145",
        "A0146",
        "A0147",
        "A0148",
        "A0149",
        "A0150",
        "A0151"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.9_2",
      "groupLabel": "Criterion EXC_5.2.4.9 - NOT",
      "internalLogic": "NOT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0152"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.9_root",
      "groupLabel": "Criterion EXC_5.2.4.9 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0145",
        "A0146",
        "A0147",
        "A0148",
        "A0149",
        "A0150",
        "A0151",
        "A0152"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.11_1a",
      "groupLabel": "Criterion EXC_5.2.4.11 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0154",
        "A0155"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.12_1a_op",
      "groupLabel": "Criterion EXC_5.2.4.12 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0156",
        "A0157",
        "A0158"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.12_1",
      "groupLabel": "Criterion EXC_5.2.4.12 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0156",
        "A0157",
        "A0158",
        "A0159",
        "A0160",
        "A0161",
        "A0162",
        "A0163",
        "A0164",
        "A0165",
        "A0166"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.12_root",
      "groupLabel": "Criterion EXC_5.2.4.12 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0156",
        "A0157",
        "A0158",
        "A0159",
        "A0160",
        "A0161",
        "A0162",
        "A0163",
        "A0164",
        "A0165",
        "A0166",
        "A0167"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.13_2",
      "groupLabel": "Criterion EXC_5.2.4.13 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0169",
        "A0170"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.13_root",
      "groupLabel": "Criterion EXC_5.2.4.13 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0168",
        "A0169",
        "A0170"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.15_2c",
      "groupLabel": "Criterion EXC_5.2.4.15 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0176",
        "A0177",
        "A0178"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.15_2",
      "groupLabel": "Criterion EXC_5.2.4.15 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0173",
        "A0174",
        "A0175",
        "A0176",
        "A0177",
        "A0178"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.15_root",
      "groupLabel": "Criterion EXC_5.2.4.15 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0172",
        "A0173",
        "A0174",
        "A0175",
        "A0176",
        "A0177",
        "A0178"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.16_2a",
      "groupLabel": "Criterion EXC_5.2.4.16 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0180",
        "A0181"
      ]
    },
    {
      "groupId": "G_EXC_5.2.4.16_root",
      "groupLabel": "Criterion EXC_5.2.4.16 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "NOT",
      "isExclusion": true,
      "atomicIds": [
        "A0179",
        "A0180",
        "A0181"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.1_1a",
      "groupLabel": "Criterion INC_5.2.5.1 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0183",
        "A0184"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.1_1b",
      "groupLabel": "Criterion INC_5.2.5.1 - EXCEPT",
      "internalLogic": "EXCEPT",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0185",
        "A0186"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.1_1",
      "groupLabel": "Criterion INC_5.2.5.1 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0183",
        "A0184",
        "A0185",
        "A0186"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.1_root",
      "groupLabel": "Criterion INC_5.2.5.1 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0183",
        "A0184",
        "A0185",
        "A0186",
        "A0187"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.2_1b_req",
      "groupLabel": "Criterion INC_5.2.5.2 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0190",
        "A0191"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.2_1b",
      "groupLabel": "Criterion INC_5.2.5.2 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0189",
        "A0190",
        "A0191"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.2_2b",
      "groupLabel": "Criterion INC_5.2.5.2 - IMPLICATION",
      "internalLogic": "IMPLICATION",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0193",
        "A0194"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.2_root",
      "groupLabel": "Criterion INC_5.2.5.2 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0188",
        "A0189",
        "A0190",
        "A0191",
        "A0192",
        "A0193",
        "A0194",
        "A0195",
        "A0196",
        "A0197"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.3_4b",
      "groupLabel": "Criterion INC_5.2.5.3 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0203",
        "A0204"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.3_4",
      "groupLabel": "Criterion INC_5.2.5.3 - OR",
      "internalLogic": "OR",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0202",
        "A0203",
        "A0204"
      ]
    },
    {
      "groupId": "G_INC_5.2.5.3_root",
      "groupLabel": "Criterion INC_5.2.5.3 - AND",
      "internalLogic": "AND",
      "combineWithOthers": "AND",
      "isExclusion": false,
      "atomicIds": [
        "A0198",
        "A0199",
        "A0200",
        "A0201",
        "A0202",
        "A0203",
        "A0204"
      ]
    }
  ],
  "expressionTree": {
    "criteria": {
      "INC_5.2.1.1": {
        "criterionId": "INC_5.2.1.1",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Age >= 18 years",
          "omopTable": "observation",
          "numericConstraintStructured": {
            "value": 18,
            "operator": ">=",
            "unit": "years",
            "parameter": "age"
          },
          "strategy": "This is a standard requirement to ensure subjects are legal adults for consent and regulatory purposes.",
          "clinicalCategory": "demographics",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_5.2.1.2": {
        "criterionId": "INC_5.2.1.2",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "atomic",
                  "atomicText": "Relapsed Chronic Lymphocytic Leukemia (CLL)",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies patients with a diagnosis of CLL that has progressed after a prior response to therapy.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "cll_relapsed_refractory_status"
                },
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "Refractory Chronic Lymphocytic Leukemia (CLL)",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identifies patients with a diagnosis of CLL that did not respond to or progressed during the most recent therapy.",
                  "clinicalCategory": "disease_indication",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "cll_relapsed_refractory_status"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Requires treatment in the opinion of the investigator",
              "omopTable": "observation",
              "strategy": "This is a clinical judgment call by the investigator to confirm that the patient's disease state warrants therapeutic intervention. It is not queryable from structured data.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "INC_5.2.1.3": {
        "criterionId": "INC_5.2.1.3",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Eastern Cooperative Oncology Group performance score of <= 1",
          "omopTable": "observation",
          "numericRangeStructured": {
            "min": 0,
            "max": 1,
            "unit": null,
            "parameter": "Eastern Cooperative Oncology Group performance score"
          },
          "strategy": "This is a standard measure of a patient's functional status. A score of 0 or 1 indicates that the patient is ambulatory and capable of carrying out at least light work, which is a common requirement for trial participation.",
          "clinicalCategory": "performance_status",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_5.2.1.4": {
        "criterionId": "INC_5.2.1.4",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1a_condition",
            "nodeType": "atomic",
            "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
            "omopTable": "drug_exposure",
            "strategy": "Identifies the cohort of patients on SSRIs to whom the stability requirement applies.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable"
          },
          "requirement": {
            "nodeId": "1b_requirement",
            "nodeType": "atomic",
            "atomicText": "Receiving a stable dose of SSRI anti-depressant",
            "omopTable": "drug_exposure",
            "timeConstraint": "for at least 21 days prior to the first dose of study drug",
            "timeFrameStructured": {
              "value": 21,
              "unit": "days",
              "operator": "before",
              "relativeEvent": "first_dose"
            },
            "strategy": "Ensures that the effect of the SSRI is not a confounding variable by requiring a consistent baseline state. This requires checking drug exposure records in the 21 days preceding the first dose to confirm a constant dosage.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "requires_manual"
          }
        }
      },
      "INC_5.2.1.5": {
        "criterionId": "INC_5.2.1.5",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "1a1",
                      "nodeType": "atomic",
                      "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL",
                      "omopTable": "measurement",
                      "numericConstraintStructured": {
                        "value": 1000,
                        "operator": ">=",
                        "unit": "/\u03bcL",
                        "parameter": "Absolute Neutrophil Count"
                      },
                      "strategy": "Assesses hematopoietic function (neutrophils).",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "1a2a",
                      "nodeType": "atomic",
                      "atomicText": "Platelets >= 75,000/mm3",
                      "omopTable": "measurement",
                      "numericConstraintStructured": {
                        "value": 75000,
                        "operator": ">=",
                        "unit": "/mm3",
                        "parameter": "Platelet Count"
                      },
                      "strategy": "Assesses hematopoietic function (platelets).",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "1a2b",
                      "nodeType": "operator",
                      "operator": "NOT",
                      "operands": [
                        {
                          "nodeId": "1a2b1",
                          "nodeType": "temporal",
                          "temporalConstraint": {
                            "operator": "WITHIN",
                            "anchor": "Screening",
                            "value": 14,
                            "unit": "days"
                          },
                          "operand": {
                            "nodeId": "1a2b1a",
                            "nodeType": "atomic",
                            "atomicText": "Received platelet transfusion",
                            "omopTable": "procedure_occurrence",
                            "strategy": "Ensures platelet count is not artificially inflated by recent transfusion.",
                            "clinicalCategory": "organ_function",
                            "queryableStatus": "fully_queryable"
                          }
                        }
                      ]
                    },
                    {
                      "nodeId": "1a3",
                      "nodeType": "atomic",
                      "atomicText": "Hemoglobin >= 9.0 g/dL",
                      "omopTable": "measurement",
                      "numericConstraintStructured": {
                        "value": 9.0,
                        "operator": ">=",
                        "unit": "g/dL",
                        "parameter": "Hemoglobin"
                      },
                      "strategy": "Assesses hematopoietic function (red blood cells).",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "1a4",
                      "nodeType": "operator",
                      "operator": "NOT",
                      "operands": [
                        {
                          "nodeId": "1a4a",
                          "nodeType": "atomic",
                          "atomicText": "Received growth factor support",
                          "omopTable": "drug_exposure",
                          "strategy": "Ensures bone marrow function is adequate without stimulation from drugs like G-CSF.",
                          "clinicalCategory": "organ_function",
                          "queryableStatus": "fully_queryable"
                        }
                      ]
                    }
                  ]
                },
                {
                  "nodeId": "1b",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "1b1",
                      "nodeType": "atomic",
                      "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL",
                      "omopTable": "measurement",
                      "numericConstraintStructured": {
                        "value": 1000,
                        "operator": "<",
                        "unit": "/\u03bcL",
                        "parameter": "Absolute Neutrophil Count"
                      },
                      "strategy": "Part of the exception criteria for patients with low ANC due to disease.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "1b2",
                      "nodeType": "atomic",
                      "atomicText": "Bone marrow heavily infiltrated with underlying disease (80% or more)",
                      "omopTable": "observation",
                      "numericConstraintStructured": {
                        "value": 80,
                        "operator": ">=",
                        "unit": "%",
                        "parameter": "Bone marrow infiltration"
                      },
                      "strategy": "Part of the exception criteria where low blood counts are attributable to disease burden.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Serum creatinine <= 2.0 mg/dL",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 2.0,
                    "operator": "<=",
                    "unit": "mg/dL",
                    "parameter": "Serum creatinine"
                  },
                  "strategy": "Assesses renal function via serum creatinine.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Calculated creatinine clearance >= 50 mL/min",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 50,
                    "operator": ">=",
                    "unit": "mL/min",
                    "parameter": "Creatinine clearance"
                  },
                  "strategy": "Assesses renal function via calculated clearance, often using Cockcroft-Gault.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "partially_queryable"
                }
              ]
            },
            {
              "nodeId": "3a",
              "nodeType": "atomic",
              "atomicText": "AST <= 3.0 x the upper normal limit (ULN)",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 3.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "Aspartate aminotransferase (AST)"
              },
              "strategy": "Assesses hepatic function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "3b",
              "nodeType": "atomic",
              "atomicText": "ALT <= 3.0 x the upper normal limit (ULN)",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 3.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "Alanine aminotransferase (ALT)"
              },
              "strategy": "Assesses hepatic function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "3c",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "3c1",
                  "nodeType": "atomic",
                  "atomicText": "Total Bilirubin <= 1.5 x ULN",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 1.5,
                    "operator": "<=",
                    "unit": "x ULN",
                    "parameter": "Total Bilirubin"
                  },
                  "strategy": "Standard requirement for bilirubin as a measure of hepatic function.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "3c2",
                  "nodeType": "atomic",
                  "atomicText": "Subject has Gilbert's Syndrome",
                  "omopTable": "condition_occurrence",
                  "strategy": "Allows for elevated bilirubin if caused by the benign condition Gilbert's Syndrome.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable"
                }
              ]
            },
            {
              "nodeId": "4a",
              "nodeType": "atomic",
              "atomicText": "aPTT not to exceed 1.2 x ULN",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 1.2,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "Activated partial thromboplastin time (aPTT)"
              },
              "strategy": "Assesses coagulation function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "4b",
              "nodeType": "atomic",
              "atomicText": "PT not to exceed 1.2 x ULN",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 1.2,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "Prothrombin time (PT)"
              },
              "strategy": "Assesses coagulation function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            }
          ]
        }
      },
      "INC_5.2.1.6": {
        "criterionId": "INC_5.2.1.6",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Subject is female",
              "omopTable": "person",
              "strategy": "Filter for patients with gender recorded as female.",
              "clinicalCategory": "demographics",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Surgically sterile",
                  "omopTable": "procedure_occurrence",
                  "strategy": "Identify subjects with a history of hysterectomy, bilateral oophorectomy, or bilateral salpingectomy.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Postmenopausal for at least 1 year",
                  "omopTable": "observation",
                  "timeConstraint": "for at least 1 year",
                  "strategy": "Identify postmenopausal status based on diagnosis codes or documented amenorrhea for at least 12 months.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2c",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "2c1",
                      "nodeType": "operator",
                      "operator": "NOT",
                      "operands": [
                        {
                          "nodeId": "2c1a",
                          "nodeType": "temporal",
                          "temporalConstraint": {
                            "operator": "WITHIN",
                            "anchor": "first_dose",
                            "value": 14,
                            "unit": "days"
                          },
                          "operand": {
                            "nodeId": "2c1a1",
                            "nodeType": "atomic",
                            "atomicText": "Positive serum pregnancy test result at Screening",
                            "omopTable": "measurement",
                            "valueConstraint": "Positive result for serum hCG test.",
                            "timeConstraint": "At Screening",
                            "strategy": "Query for serum pregnancy test results with a positive outcome during the screening period.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "screening_only"
                          }
                        }
                      ]
                    },
                    {
                      "nodeId": "2c2",
                      "nodeType": "operator",
                      "operator": "IMPLICATION",
                      "condition": {
                        "nodeId": "2c2_cond",
                        "nodeType": "atomic",
                        "atomicText": "More than 7 days between obtaining serum pregnancy test and initial study drug administration",
                        "omopTable": "measurement",
                        "timeConstraint": "> 7 days",
                        "strategy": "Calculate the time difference between the serum pregnancy test date and the first dose date.",
                        "clinicalCategory": "demographics",
                        "queryableStatus": "screening_only"
                      },
                      "requirement": {
                        "nodeId": "2c2_req",
                        "nodeType": "operator",
                        "operator": "NOT",
                        "operands": [
                          {
                            "nodeId": "2c2_req_a",
                            "nodeType": "temporal",
                            "temporalConstraint": {
                              "operator": "BEFORE",
                              "anchor": "first_dose"
                            },
                            "operand": {
                              "nodeId": "2c2_req_a1",
                              "nodeType": "atomic",
                              "atomicText": "Positive urine pregnancy test on Cycle 1 Day 1 or Lead-in Day 1",
                              "omopTable": "measurement",
                              "valueConstraint": "Positive result for urine hCG test.",
                              "timeConstraint": "On Cycle 1 Day 1 or Lead-in Day 1",
                              "strategy": "Query for urine pregnancy test results with a positive outcome on the day of initial dosing.",
                              "clinicalCategory": "demographics",
                              "queryableStatus": "screening_only"
                            }
                          }
                        ]
                      }
                    }
                  ]
                }
              ]
            }
          ]
        }
      },
      "INC_5.2.1.7": {
        "criterionId": "INC_5.2.1.7",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "c1",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "c1a",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "c1a1",
                    "nodeType": "atomic",
                    "atomicText": "Gender is Female",
                    "omopTable": "person",
                    "strategy": "Identifies female subjects.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "fully_queryable"
                  },
                  {
                    "nodeId": "c1a2",
                    "nodeType": "operator",
                    "operator": "NOT",
                    "operands": [
                      {
                        "nodeId": "c1a2_op",
                        "nodeType": "operator",
                        "operator": "OR",
                        "operands": [
                          {
                            "nodeId": "c1a2a",
                            "nodeType": "atomic",
                            "atomicText": "Surgically sterile",
                            "omopTable": "procedure_occurrence",
                            "strategy": "Identifies conditions like hysterectomy, bilateral oophorectomy, or tubal ligation.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "partially_queryable",
                            "clinicalConceptGroup": "female_sterility"
                          },
                          {
                            "nodeId": "c1a2b",
                            "nodeType": "atomic",
                            "atomicText": "Postmenopausal for at least 1 year",
                            "omopTable": "observation",
                            "timeConstraint": "for at least 1 year",
                            "timeFrameStructured": {
                              "value": 1,
                              "unit": "year",
                              "operator": "at_least",
                              "relativeEvent": "current_date"
                            },
                            "strategy": "Identifies postmenopausal status, defined as 12 months of amenorrhea.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "partially_queryable",
                            "clinicalConceptGroup": "female_sterility"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "nodeId": "c1b",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "c1b1",
                    "nodeType": "atomic",
                    "atomicText": "Gender is Male",
                    "omopTable": "person",
                    "strategy": "Identifies male subjects.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "fully_queryable"
                  },
                  {
                    "nodeId": "c1b2",
                    "nodeType": "operator",
                    "operator": "NOT",
                    "operands": [
                      {
                        "nodeId": "c1b2a",
                        "nodeType": "atomic",
                        "atomicText": "Subject has had a vasectomy",
                        "omopTable": "procedure_occurrence",
                        "strategy": "Identifies males who are surgically sterile.",
                        "clinicalCategory": "demographics",
                        "queryableStatus": "fully_queryable"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "requirement": {
            "nodeId": "r1",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "r1a",
                "nodeType": "atomic",
                "atomicText": "Total abstinence from sexual intercourse for at least one complete menstrual cycle",
                "omopTable": "observation",
                "timeConstraint": "minimum one complete menstrual cycle",
                "strategy": "Patient-reported abstinence. One of the acceptable birth control methods.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "birth_control_method"
              },
              {
                "nodeId": "r1b",
                "nodeType": "atomic",
                "atomicText": "Partner is vasectomized",
                "omopTable": "observation",
                "strategy": "Patient-reported partner status. One of the acceptable birth control methods.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "birth_control_method"
              },
              {
                "nodeId": "r1c",
                "nodeType": "atomic",
                "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
                "omopTable": "drug_exposure",
                "timeConstraint": "for at least 3 months prior to study drug administration",
                "timeFrameStructured": {
                  "value": 3,
                  "unit": "months",
                  "operator": "before",
                  "relativeEvent": "study drug administration"
                },
                "strategy": "Verifies use of hormonal contraception for a sufficient duration before the study. One of the acceptable birth control methods.",
                "clinicalCategory": "demographics",
                "queryableStatus": "fully_queryable",
                "clinicalConceptGroup": "birth_control_method"
              },
              {
                "nodeId": "r1d",
                "nodeType": "atomic",
                "atomicText": "Use of double-barrier method",
                "omopTable": "observation",
                "strategy": "Includes condoms, contraceptive sponge, diaphragm or vaginal ring with spermicidal jellies or cream. One of the acceptable birth control methods.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "birth_control_method"
              }
            ]
          }
        }
      },
      "INC_5.2.1.8": {
        "criterionId": "INC_5.2.1.8",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Informed consent was given voluntarily",
              "omopTable": "observation",
              "strategy": "Ensures the patient's participation is willing and not coerced. This is assessed and documented by site staff.",
              "clinicalCategory": "diagnostic_confirmation",
              "queryableStatus": "screening_only"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Informed consent form is approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
              "omopTable": "observation",
              "strategy": "Confirms that the study protocol and consent documentation meet required ethical standards. This is a study-level requirement verified at the site.",
              "clinicalCategory": "diagnostic_confirmation",
              "queryableStatus": "screening_only"
            },
            {
              "nodeId": "3",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "BEFORE",
                "anchor": "initiation of any screening or study-specific procedures"
              },
              "operand": {
                "nodeId": "3a",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "3a1",
                    "nodeType": "atomic",
                    "atomicText": "Subject has signed an informed consent form",
                    "omopTable": "observation",
                    "strategy": "Documents the patient's formal agreement to participate in the trial. Verified via source document review.",
                    "clinicalCategory": "diagnostic_confirmation",
                    "queryableStatus": "screening_only",
                    "clinicalConceptGroup": "informed_consent_documentation"
                  },
                  {
                    "nodeId": "3a2",
                    "nodeType": "atomic",
                    "atomicText": "The signed informed consent form is dated",
                    "omopTable": "observation",
                    "strategy": "Establishes the specific date on which the patient provided consent. Verified via source document review.",
                    "clinicalCategory": "diagnostic_confirmation",
                    "queryableStatus": "screening_only",
                    "clinicalConceptGroup": "informed_consent_documentation"
                  }
                ]
              }
            }
          ]
        }
      },
      "EXC_5.2.2.1": {
        "criterionId": "EXC_5.2.2.1",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
              "omopTable": "condition_occurrence",
              "strategy": "Checks for a formal diagnosis of CNS disease related to cancer, such as brain metastases or primary CNS tumors, in the patient's medical history.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "cancer_related_cns_disease"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
              "omopTable": "observation",
              "strategy": "Captures clinical judgment where CNS disease is suspected based on symptoms or signs, even without a confirmed diagnosis. This typically requires manual chart review.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cancer_related_cns_disease"
            }
          ]
        }
      },
      "EXC_5.2.2.2": {
        "criterionId": "EXC_5.2.2.2",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Undergone an allogeneic stem cell transplant",
              "omopTable": "procedure_occurrence",
              "strategy": "Identifies patients who have received a stem cell transplant from a donor. This is a significant prior medical procedure.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "stem_cell_transplant"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Undergone an autologous stem cell transplant",
              "omopTable": "procedure_occurrence",
              "strategy": "Identifies patients who have received a stem cell transplant using their own cells. This is a significant prior medical procedure.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "stem_cell_transplant"
            }
          ]
        }
      },
      "EXC_5.2.2.3": {
        "criterionId": "EXC_5.2.2.3",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 1,
                "unit": "year"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Underlying, predisposing condition of bleeding",
                "omopTable": "condition_occurrence",
                "timeConstraint": "within 1 year prior to first dose of study drug",
                "timeFrameStructured": {
                  "value": 1,
                  "unit": "year",
                  "operator": "within",
                  "relativeEvent": "first_dose"
                },
                "strategy": "Identifies subjects with a known medical history that increases bleeding risk, such as coagulopathies, severe thrombocytopenia, or recent major surgery.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "partially_queryable"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Currently exhibits signs of bleeding",
              "omopTable": "observation",
              "timeConstraint": "current",
              "strategy": "Identifies subjects with active bleeding at the time of study entry, which is a direct safety contraindication. This is typically assessed at screening or baseline.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_5.2.2.4": {
        "criterionId": "EXC_5.2.2.4",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active peptic ulcer disease",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with a current or recent diagnosis of peptic ulcer disease, which poses a significant bleeding risk.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "gi_bleeding_risk"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Potentially hemorrhagic esophagitis",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with esophagitis that has a hemorrhagic component or potential, excluding them due to bleeding risk. This may require identifying specific subtypes or co-occurring bleeding diagnoses.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "gi_bleeding_risk"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Potentially hemorrhagic gastritis",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with gastritis that has a hemorrhagic component or potential, excluding them due to bleeding risk. This may require identifying specific subtypes or co-occurring bleeding diagnoses.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "gi_bleeding_risk"
            }
          ]
        }
      },
      "EXC_5.2.2.5": {
        "criterionId": "EXC_5.2.2.5",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active immune thrombocytopenic purpura",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with the primary diagnosis of active ITP.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 1,
                "unit": "year"
              },
              "operand": {
                "nodeId": "2a",
                "nodeType": "atomic",
                "atomicText": "History of being refractory to platelet transfusions",
                "omopTable": "observation",
                "timeConstraint": "within 1 year prior to the first dose of study drug",
                "strategy": "Identifies subjects with a documented history of failing to respond to platelet transfusions. This is often a clinical assessment based on post-transfusion platelet counts.",
                "clinicalCategory": "disease_indication",
                "queryableStatus": "partially_queryable"
              }
            }
          ]
        }
      },
      "EXC_5.2.2.6": {
        "criterionId": "EXC_5.2.2.6",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 7,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Received aspirin",
            "omopTable": "drug_exposure",
            "timeConstraint": "within 7 days prior to the first dose of study drug",
            "timeFrameStructured": {
              "value": 7,
              "unit": "days",
              "operator": "within",
              "relativeEvent": "first_dose"
            },
            "strategy": "Query drug exposure records for aspirin within the 7-day window before the study drug's first dose. This is often checked to manage bleeding risk or drug interactions.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable"
          }
        }
      },
      "EXC_5.2.2.7": {
        "criterionId": "EXC_5.2.2.7",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "atomic",
                  "atomicText": "Currently receiving or requires anticoagulation therapy",
                  "omopTable": "drug_exposure",
                  "timeConstraint": "currently",
                  "strategy": "Identifies patients taking anticoagulant medications, which could pose a bleeding risk. The 'requires' clause may necessitate manual review of conditions or clinical notes.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "bleeding_risk_medication"
                },
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "Currently receiving or requires any drugs or herbal supplements that affect platelet function",
                  "omopTable": "drug_exposure",
                  "timeConstraint": "currently",
                  "strategy": "Identifies patients taking antiplatelet agents (e.g., aspirin, clopidogrel) or certain supplements (e.g., ginkgo, garlic), which pose a bleeding risk. Requires a comprehensive value set.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "bleeding_risk_medication"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Low-dose anticoagulation medications used to maintain the patency of a central intravenous catheter",
              "omopTable": "drug_exposure",
              "valueConstraint": "low-dose and for catheter patency",
              "strategy": "This is an exception for a common, low-risk use of anticoagulants like heparin flushes for IV lines. Identifying the specific indication and confirming the low dose typically requires manual chart review.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_5.2.2.8": {
        "criterionId": "EXC_5.2.2.8",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 7,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Received steroid therapy for anti-neoplastic intent",
                "omopTable": "drug_exposure",
                "strategy": "Identifies patients receiving high-dose or systemic steroids for cancer treatment, which could interfere with the study drug's mechanism or safety profile. This is a common exclusion to avoid confounding effects.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "partially_queryable"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Received inhaled steroids for asthma",
                  "omopTable": "drug_exposure",
                  "strategy": "This is a permitted exception because inhaled steroids have minimal systemic absorption and are unlikely to interfere with the study drug.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "permitted_steroids"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Received topical steroids",
                  "omopTable": "drug_exposure",
                  "strategy": "This is a permitted exception because topical steroids have minimal systemic absorption and are unlikely to interfere with the study drug.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "permitted_steroids"
                },
                {
                  "nodeId": "2c",
                  "nodeType": "atomic",
                  "atomicText": "Received replacement or stress corticosteroids",
                  "omopTable": "drug_exposure",
                  "strategy": "This is a permitted exception because these are physiological doses, not pharmacological, and are not for anti-neoplastic intent. They are necessary for patients with adrenal insufficiency.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "permitted_steroids"
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.2.9": {
        "criterionId": "EXC_5.2.2.9",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 14,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "1a1",
                    "nodeType": "atomic",
                    "atomicText": "Received chemotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for exposure to chemotherapy agents.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a2",
                    "nodeType": "atomic",
                    "atomicText": "Received immunotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for exposure to immunotherapy agents.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a3",
                    "nodeType": "atomic",
                    "atomicText": "Received radiotherapy",
                    "omopTable": "procedure_occurrence",
                    "strategy": "Check for radiotherapy procedures.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a4",
                    "nodeType": "operator",
                    "operator": "EXCEPT",
                    "operands": [
                      {
                        "nodeId": "1a4a",
                        "nodeType": "atomic",
                        "atomicText": "Received hormonal anti-cancer therapy",
                        "omopTable": "drug_exposure",
                        "strategy": "Check for exposure to hormonal therapies used for cancer treatment.",
                        "clinicalCategory": "prior_therapy",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "anti_cancer_therapy"
                      },
                      {
                        "nodeId": "1a4b",
                        "nodeType": "operator",
                        "operator": "OR",
                        "operands": [
                          {
                            "nodeId": "1a4b1",
                            "nodeType": "atomic",
                            "atomicText": "Received hormones for thyroid conditions",
                            "omopTable": "drug_exposure",
                            "strategy": "Identify hormone therapies specifically for thyroid conditions, which are allowed.",
                            "clinicalCategory": "prior_therapy",
                            "queryableStatus": "fully_queryable"
                          },
                          {
                            "nodeId": "1a4b2",
                            "nodeType": "atomic",
                            "atomicText": "Received estrogen replacement therapy (ERT)",
                            "omopTable": "drug_exposure",
                            "strategy": "Identify estrogen replacement therapies, which are allowed.",
                            "clinicalCategory": "prior_therapy",
                            "queryableStatus": "fully_queryable"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "nodeId": "1a5",
                    "nodeType": "atomic",
                    "atomicText": "Received any investigational therapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for participation in other clinical trials or receipt of investigational agents.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "partially_queryable"
                  }
                ]
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
                  "omopTable": "observation",
                  "numericConstraintStructured": {
                    "value": 2,
                    "operator": "<",
                    "unit": "grade",
                    "parameter": "CTCAE grade for adverse effect from prior therapy"
                  },
                  "strategy": "Verify that all significant toxicities from prior treatments have resolved to Grade 1 or 0. This requires chart review to link AEs to prior therapy and assess clinical significance.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.2.10": {
        "criterionId": "EXC_5.2.2.10",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 30,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Received a biologic",
            "omopTable": "drug_exposure",
            "strategy": "Query for drug exposures to any medication classified as a biologic. The temporal constraint ensures this exposure is recent relative to the start of the study drug.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable"
          }
        }
      },
      "EXC_5.2.2.11": {
        "criterionId": "EXC_5.2.2.11",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 3,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "1a1",
                "nodeType": "atomic",
                "atomicText": "Consumed grapefruit",
                "omopTable": "observation",
                "timeConstraint": "within 3 days prior to the first dose of study drug",
                "strategy": "This is a common safety exclusion to prevent drug-food interaction. Grapefruit and its products can inhibit CYP3A4 enzymes, significantly altering the metabolism and bioavailability of many study drugs.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "grapefruit_consumption"
              },
              {
                "nodeId": "1a2",
                "nodeType": "atomic",
                "atomicText": "Consumed grapefruit products",
                "omopTable": "observation",
                "timeConstraint": "within 3 days prior to the first dose of study drug",
                "strategy": "This is a common safety exclusion to prevent drug-food interaction. Grapefruit and its products can inhibit CYP3A4 enzymes, significantly altering the metabolism and bioavailability of many study drugs.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "grapefruit_consumption"
              }
            ]
          }
        }
      },
      "EXC_5.2.2.12": {
        "criterionId": "EXC_5.2.2.12",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of cardiovascular disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Captures any significant cardiovascular history not covered by the specific examples, requiring investigator assessment of 'significant'.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1b",
                  "nodeType": "temporal",
                  "temporalConstraint": {
                    "operator": "WITHIN",
                    "anchor": "screening",
                    "value": 6,
                    "unit": "months"
                  },
                  "operand": {
                    "nodeId": "1b_op",
                    "nodeType": "operator",
                    "operator": "OR",
                    "operands": [
                      {
                        "nodeId": "1b1",
                        "nodeType": "atomic",
                        "atomicText": "Myocardial infarction",
                        "omopTable": "condition_occurrence",
                        "timeConstraint": "in the last 6 months",
                        "timeFrameStructured": {
                          "value": 6,
                          "unit": "months",
                          "operator": "within",
                          "relativeEvent": "screening"
                        },
                        "strategy": "Identify subjects with a recent MI.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "recent_thromboembolic_events"
                      },
                      {
                        "nodeId": "1b2",
                        "nodeType": "atomic",
                        "atomicText": "Thrombotic event",
                        "omopTable": "condition_occurrence",
                        "timeConstraint": "in the last 6 months",
                        "timeFrameStructured": {
                          "value": 6,
                          "unit": "months",
                          "operator": "within",
                          "relativeEvent": "screening"
                        },
                        "strategy": "Identify subjects with a recent thrombotic event.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "recent_thromboembolic_events"
                      },
                      {
                        "nodeId": "1b3",
                        "nodeType": "atomic",
                        "atomicText": "Thromboembolic event",
                        "omopTable": "condition_occurrence",
                        "timeConstraint": "in the last 6 months",
                        "timeFrameStructured": {
                          "value": 6,
                          "unit": "months",
                          "operator": "within",
                          "relativeEvent": "screening"
                        },
                        "strategy": "Identify subjects with a recent thromboembolic event.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "recent_thromboembolic_events"
                      }
                    ]
                  }
                },
                {
                  "nodeId": "1c",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of renal disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant renal comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1d",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of neurologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant neurologic comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1e",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of psychiatric disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant psychiatric comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1f",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of endocrinologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant endocrinologic comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1g",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of metabolic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant metabolic comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1h",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of immunologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant immunologic comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "1i",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of hepatic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Identify subjects with significant hepatic comorbidities.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Condition would adversely affect study participation in the opinion of the investigator",
              "omopTable": "observation",
              "strategy": "This is a mandatory safety assessment by the investigator, confirming that any identified comorbidity poses a relevant risk to study participation.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_5.2.2.13": {
        "criterionId": "EXC_5.2.2.13",
        "type": "exclusion",
        "tree": {
          "nodeId": "EXC_5.2.2.13_S_and_2",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1a",
              "nodeType": "atomic",
              "atomicText": "Female",
              "omopTable": "person",
              "strategy": "Identifies subjects recorded as female sex.",
              "clinicalCategory": "demographics",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "EXC_5.2.2.13_S_or_1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "Pregnant",
                  "omopTable": "observation",
                  "strategy": "Identifies subjects with a current status of pregnant.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "fully_queryable"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Breast-feeding",
                  "omopTable": "observation",
                  "strategy": "Identifies subjects with a current status of breast-feeding.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "fully_queryable"
                }
              ]
            }
          ]
        }
      },
      "INC_5.2.3.1": {
        "criterionId": "INC_5.2.3.1",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Age >= 18 years",
          "omopTable": "observation",
          "numericConstraintStructured": {
            "value": 18,
            "operator": ">=",
            "unit": "years",
            "parameter": "age"
          },
          "strategy": "Standard requirement for adult clinical trials to ensure subjects are legally able to provide informed consent.",
          "clinicalCategory": "demographics",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_5.2.3.2": {
        "criterionId": "INC_5.2.3.2",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Has Chronic Lymphocytic Leukemia (CLL)",
              "omopTable": "condition_occurrence",
              "strategy": "Identify patients with a diagnosis code for Chronic Lymphocytic Leukemia.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Requires treatment in the opinion of the investigator",
              "omopTable": "observation",
              "strategy": "This is a subjective assessment by the clinical investigator and would typically be captured on a case report form (CRF) or through chart review. It confirms the clinical need for intervention beyond just the diagnosis.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "INC_5.2.3.3": {
        "criterionId": "INC_5.2.3.3",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Relapsed disease",
              "omopTable": "condition_occurrence",
              "strategy": "This identifies the subject's disease status, which is a primary requirement for the indication being studied.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Received 5 or fewer prior myelosuppressive/chemotherapy regimens",
              "omopTable": "drug_exposure",
              "numericConstraintStructured": {
                "value": 5,
                "operator": "<=",
                "unit": "regimens",
                "parameter": "count of prior myelosuppressive/chemotherapy regimens"
              },
              "strategy": "This limits eligibility to subjects who have not been heavily pre-treated. Counting 'regimens' typically requires manual review of treatment history to group individual drug administrations into distinct lines of therapy.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "INC_5.2.3.4": {
        "criterionId": "INC_5.2.3.4",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Eastern Cooperative Oncology Group (ECOG) performance score <= 1",
          "omopTable": "observation",
          "numericRangeStructured": {
            "min": 0,
            "max": 1,
            "unit": null,
            "parameter": "Eastern Cooperative Oncology Group performance score"
          },
          "strategy": "Assesses the patient's functional capacity. A score of 0 or 1 indicates the patient is ambulatory and capable of at least light work, a common requirement for trial participation to ensure they can tolerate potential treatment toxicities.",
          "clinicalCategory": "performance_status",
          "queryableStatus": "fully_queryable"
        }
      },
      "INC_5.2.3.5": {
        "criterionId": "INC_5.2.3.5",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Receiving Selective Serotonin Reuptake Inhibitor (SSRI) anti-depressants",
            "omopTable": "drug_exposure",
            "strategy": "Identifies the cohort of patients to whom the stable dose requirement applies.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable",
            "clinicalConceptGroup": "ssri_therapy"
          },
          "requirement": {
            "nodeId": "1b",
            "nodeType": "temporal",
            "temporalConstraint": {
              "operator": "WITHIN",
              "anchor": "first_dose_of_study_drug",
              "value": 21,
              "unit": "days"
            },
            "operand": {
              "nodeId": "1b1",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "1b1a",
                  "nodeType": "atomic",
                  "atomicText": "Dose of SSRI changed",
                  "omopTable": "drug_exposure",
                  "strategy": "A change in dose for the SSRI medication would violate the stability requirement.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "ssri_therapy"
                }
              ]
            }
          }
        }
      },
      "INC_5.2.3.6": {
        "criterionId": "INC_5.2.3.6",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1a",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "1a1",
                  "nodeType": "atomic",
                  "atomicText": "Received growth factor support to maintain bone marrow function",
                  "omopTable": "drug_exposure",
                  "strategy": "Ensures bone marrow counts are not artificially inflated by support medications like G-CSF. Timeframe for this is often within 2-4 weeks of screening.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable"
                }
              ]
            },
            {
              "nodeId": "1b",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1b1",
                  "nodeType": "atomic",
                  "atomicText": "Absolute Neutrophil count (ANC) >= 1000/\u03bcL at Screening",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 1000,
                    "operator": ">=",
                    "unit": "/\u03bcL",
                    "parameter": "ANC"
                  },
                  "strategy": "Standard requirement for adequate neutrophil count.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable"
                },
                {
                  "nodeId": "1b2",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "1b2a",
                      "nodeType": "atomic",
                      "atomicText": "Absolute Neutrophil count (ANC) < 1000/\u03bcL at Screening",
                      "omopTable": "measurement",
                      "numericConstraintStructured": {
                        "value": 1000,
                        "operator": "<",
                        "unit": "/\u03bcL",
                        "parameter": "ANC"
                      },
                      "strategy": "Condition for the exception: low neutrophil count.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "1b2b",
                      "nodeType": "atomic",
                      "atomicText": "Bone marrow heavily infiltrated with underlying disease >= 80% at Screening",
                      "omopTable": "observation",
                      "numericConstraintStructured": {
                        "value": 80,
                        "operator": ">=",
                        "unit": "%",
                        "parameter": "Bone marrow infiltration"
                      },
                      "strategy": "Allows patients with low ANC due to heavy disease burden in the marrow to be eligible.",
                      "clinicalCategory": "disease_indication",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                }
              ]
            },
            {
              "nodeId": "1c1",
              "nodeType": "atomic",
              "atomicText": "Platelets >= 75,000/mm3 at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 75000,
                "operator": ">=",
                "unit": "/mm3",
                "parameter": "Platelets"
              },
              "strategy": "Standard requirement for adequate platelet count.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "1c2",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "1c2a",
                  "nodeType": "temporal",
                  "temporalConstraint": {
                    "operator": "WITHIN",
                    "anchor": "Screening",
                    "value": 14,
                    "unit": "days"
                  },
                  "operand": {
                    "nodeId": "1c2a1",
                    "nodeType": "atomic",
                    "atomicText": "Received platelet transfusion",
                    "omopTable": "procedure_occurrence",
                    "strategy": "Ensures the platelet count is not artificially supported by a recent transfusion.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable"
                  }
                }
              ]
            },
            {
              "nodeId": "1d",
              "nodeType": "atomic",
              "atomicText": "Hemoglobin >= 9.0 g/dL at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 9.0,
                "operator": ">=",
                "unit": "g/dL",
                "parameter": "Hemoglobin"
              },
              "strategy": "Standard requirement for adequate hemoglobin level.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Serum creatinine <= 2.0 mg/dL at Screening",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 2.0,
                    "operator": "<=",
                    "unit": "mg/dL",
                    "parameter": "Serum creatinine"
                  },
                  "strategy": "Measures renal function via creatinine level.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Calculated creatinine clearance >= 50 mL/min at Screening",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 50,
                    "operator": ">=",
                    "unit": "mL/min",
                    "parameter": "Creatinine clearance"
                  },
                  "strategy": "Measures renal function via creatinine clearance, often calculated.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable"
                }
              ]
            },
            {
              "nodeId": "3a",
              "nodeType": "atomic",
              "atomicText": "AST <= 3.0 x ULN at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 3.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "AST"
              },
              "strategy": "Measures hepatic function via AST enzyme level relative to the institution's upper limit of normal.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "3b",
              "nodeType": "atomic",
              "atomicText": "ALT <= 3.0 x ULN at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 3.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "ALT"
              },
              "strategy": "Measures hepatic function via ALT enzyme level relative to the institution's upper limit of normal.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "3c",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "3c1",
                  "nodeType": "atomic",
                  "atomicText": "Bilirubin <= 1.5 x ULN at Screening",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 1.5,
                    "operator": "<=",
                    "unit": "x ULN",
                    "parameter": "Bilirubin"
                  },
                  "strategy": "Measures hepatic function via Bilirubin level.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "3c2",
                  "nodeType": "atomic",
                  "atomicText": "Subject has diagnosis of Gilbert's Syndrome",
                  "omopTable": "condition_occurrence",
                  "strategy": "Allows subjects with Gilbert's Syndrome, who have benignly elevated bilirubin, to be eligible.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "fully_queryable"
                }
              ]
            },
            {
              "nodeId": "4a",
              "nodeType": "atomic",
              "atomicText": "aPTT must not exceed 1.2 x ULN at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 1.2,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "aPTT"
              },
              "strategy": "Measures coagulation status relative to institution's upper limit of normal.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "4b",
              "nodeType": "atomic",
              "atomicText": "PT must not exceed 1.2 x ULN at Screening",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 1.2,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "PT"
              },
              "strategy": "Measures coagulation status relative to institution's upper limit of normal.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            }
          ]
        }
      },
      "INC_5.2.3.7": {
        "criterionId": "INC_5.2.3.7",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "0",
              "nodeType": "atomic",
              "atomicText": "Female sex",
              "omopTable": "person",
              "valueConstraint": "Female",
              "strategy": "The criterion is specific to female subjects.",
              "clinicalCategory": "demographics",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "main_or",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1",
                  "nodeType": "atomic",
                  "atomicText": "Surgically sterile",
                  "omopTable": "procedure_occurrence",
                  "strategy": "Identifies subjects who are sterile due to procedures like hysterectomy or bilateral oophorectomy.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2",
                  "nodeType": "atomic",
                  "atomicText": "Postmenopausal for at least 1 year",
                  "omopTable": "observation",
                  "timeConstraint": "for at least 1 year",
                  "numericConstraintStructured": {
                    "value": 1,
                    "operator": ">=",
                    "unit": "year",
                    "parameter": "duration of postmenopausal state"
                  },
                  "strategy": "Identifies subjects who are naturally non-childbearing due to menopause.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "requires_manual"
                },
                {
                  "nodeId": "3",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "3a",
                      "nodeType": "operator",
                      "operator": "NOT",
                      "operands": [
                        {
                          "nodeId": "3a1",
                          "nodeType": "temporal",
                          "temporalConstraint": {
                            "operator": "WITHIN",
                            "anchor": "initial study drug administration",
                            "value": 14,
                            "unit": "days"
                          },
                          "operand": {
                            "nodeId": "3a1a",
                            "nodeType": "atomic",
                            "atomicText": "Positive serum pregnancy test at Screening",
                            "omopTable": "measurement",
                            "valueConstraint": "Positive",
                            "strategy": "A positive serum pregnancy test within 14 days of the first dose is exclusionary.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "screening_only",
                            "clinicalConceptGroup": "pregnancy_test"
                          }
                        }
                      ]
                    },
                    {
                      "nodeId": "3b",
                      "nodeType": "operator",
                      "operator": "IMPLICATION",
                      "condition": {
                        "nodeId": "3b_cond",
                        "nodeType": "atomic",
                        "atomicText": "Time since serum pregnancy test results > 7 days on Lead-in Day 1",
                        "omopTable": "observation",
                        "numericConstraintStructured": {
                          "value": 7,
                          "operator": ">",
                          "unit": "days",
                          "parameter": "time between serum pregnancy test and Lead-in Day 1"
                        },
                        "strategy": "This condition triggers the requirement for a second pregnancy test if the initial one is too old.",
                        "clinicalCategory": "demographics",
                        "queryableStatus": "screening_only"
                      },
                      "requirement": {
                        "nodeId": "3b_req",
                        "nodeType": "operator",
                        "operator": "NOT",
                        "operands": [
                          {
                            "nodeId": "3b_req1",
                            "nodeType": "atomic",
                            "atomicText": "Positive urine pregnancy test prior to dosing on Lead-in Day 1",
                            "omopTable": "measurement",
                            "valueConstraint": "Positive",
                            "timeConstraint": "prior to dosing on Lead-in Day 1",
                            "strategy": "A positive urine pregnancy test just before dosing is exclusionary.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "screening_only",
                            "clinicalConceptGroup": "pregnancy_test"
                          }
                        ]
                      }
                    }
                  ]
                }
              ]
            }
          ]
        }
      },
      "INC_5.2.3.8": {
        "criterionId": "INC_5.2.3.8",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "IMPLICATION",
          "condition": {
            "nodeId": "c",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "c1",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "c1a",
                    "nodeType": "atomic",
                    "atomicText": "Female",
                    "omopTable": "person",
                    "strategy": "Identify female subjects.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "fully_queryable"
                  },
                  {
                    "nodeId": "c1b",
                    "nodeType": "operator",
                    "operator": "NOT",
                    "operands": [
                      {
                        "nodeId": "c1b_or",
                        "nodeType": "operator",
                        "operator": "OR",
                        "operands": [
                          {
                            "nodeId": "c1b1",
                            "nodeType": "atomic",
                            "atomicText": "Surgically sterile",
                            "omopTable": "procedure_occurrence",
                            "strategy": "Identify females who are surgically sterile (e.g., hysterectomy, bilateral salpingo-oophorectomy).",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "partially_queryable",
                            "clinicalConceptGroup": "female_not_childbearing_potential"
                          },
                          {
                            "nodeId": "c1b2",
                            "nodeType": "atomic",
                            "atomicText": "Postmenopausal for at least 1 year",
                            "omopTable": "observation",
                            "timeConstraint": "for at least 1 year",
                            "strategy": "Identify females who are postmenopausal, defined as amenorrhea for at least 1 year.",
                            "clinicalCategory": "demographics",
                            "queryableStatus": "requires_manual",
                            "clinicalConceptGroup": "female_not_childbearing_potential"
                          }
                        ]
                      }
                    ]
                  }
                ]
              },
              {
                "nodeId": "c2",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "c2a",
                    "nodeType": "atomic",
                    "atomicText": "Male",
                    "omopTable": "person",
                    "strategy": "Identify male subjects.",
                    "clinicalCategory": "demographics",
                    "queryableStatus": "fully_queryable"
                  },
                  {
                    "nodeId": "c2b",
                    "nodeType": "operator",
                    "operator": "NOT",
                    "operands": [
                      {
                        "nodeId": "c2b1",
                        "nodeType": "atomic",
                        "atomicText": "History of vasectomy",
                        "omopTable": "procedure_occurrence",
                        "strategy": "Identify males who have had a vasectomy.",
                        "clinicalCategory": "demographics",
                        "queryableStatus": "partially_queyrable"
                      }
                    ]
                  }
                ]
              }
            ]
          },
          "requirement": {
            "nodeId": "r",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "r1",
                "nodeType": "atomic",
                "atomicText": "Practices total abstinence from sexual intercourse for a minimum of one complete menstrual cycle",
                "omopTable": "observation",
                "strategy": "Confirm subject attestation of total abstinence.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "contraception_method"
              },
              {
                "nodeId": "r2",
                "nodeType": "atomic",
                "atomicText": "Partner is vasectomized",
                "omopTable": "observation",
                "strategy": "Confirm subject attestation of partner's vasectomy.",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "contraception_method"
              },
              {
                "nodeId": "r3",
                "nodeType": "atomic",
                "atomicText": "Use of hormonal contraceptives (oral, parenteral or transdermal) for at least 3 months prior to study drug administration",
                "omopTable": "drug_exposure",
                "timeConstraint": "for at least 3 months prior to study drug administration",
                "strategy": "Confirm use of hormonal contraceptives for a sufficient duration before the study.",
                "clinicalCategory": "demographics",
                "queryableStatus": "partially_queryable",
                "clinicalConceptGroup": "contraception_method"
              },
              {
                "nodeId": "r4",
                "nodeType": "atomic",
                "atomicText": "Practices double-barrier method of birth control",
                "omopTable": "observation",
                "strategy": "Confirm subject attestation of using double-barrier contraception (e.g., condom with spermicide).",
                "clinicalCategory": "demographics",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "contraception_method"
              }
            ]
          }
        }
      },
      "INC_5.2.3.9": {
        "criterionId": "INC_5.2.3.9",
        "type": "inclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "BEFORE",
            "anchor": "initiation of any screening or study-specific procedures"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Subject has voluntarily signed and dated an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB)",
            "omopTable": "observation",
            "strategy": "This is a core ethical and procedural requirement. Verification is done by manually reviewing the signed and dated Informed Consent Form (ICF) in the subject's source documents to confirm the signature date precedes the date of any study-related procedure. The ICF version must match the one approved by the IEC/IRB.",
            "clinicalCategory": "diagnostic_confirmation",
            "queryableStatus": "requires_manual"
          }
        }
      },
      "EXC_5.2.4.1": {
        "criterionId": "EXC_5.2.4.1",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "History of cancer-related Central Nervous System (CNS) disease",
              "omopTable": "condition_occurrence",
              "strategy": "Query for condition codes related to CNS metastases, leptomeningeal disease, or primary CNS tumors in the context of another cancer.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "cns_disease_presence"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Clinically suspicious for cancer-related Central Nervous System (CNS) disease",
              "omopTable": "observation",
              "strategy": "This requires manual review of recent clinical notes, imaging reports (e.g., MRI, CT of the brain), or documented neurological symptoms that raise suspicion for CNS involvement.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "cns_disease_presence"
            }
          ]
        }
      },
      "EXC_5.2.4.2": {
        "criterionId": "EXC_5.2.4.2",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose_of_study_drug",
                "value": 1,
                "unit": "year"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "History of an underlying, predisposing condition of bleeding",
                "omopTable": "condition_occurrence",
                "timeConstraint": "within 1 year prior to first dose of study drug",
                "timeFrameStructured": {
                  "value": 1,
                  "unit": "year",
                  "operator": "within",
                  "relativeEvent": "first_dose_of_study_drug"
                },
                "strategy": "Identifies patients with a known condition that increases bleeding risk, such as hemophilia or other coagulopathies, within the year before starting the study drug.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "partially_queryable",
                "clinicalConceptGroup": "bleeding_risk"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Currently exhibits signs of bleeding",
              "omopTable": "observation",
              "timeConstraint": "current",
              "strategy": "Identifies patients with active signs of bleeding (e.g., petechiae, hematuria, gastrointestinal bleeding) at the time of screening or baseline assessment.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual",
              "clinicalConceptGroup": "bleeding_risk"
            }
          ]
        }
      },
      "EXC_5.2.4.3": {
        "criterionId": "EXC_5.2.4.3",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Undergone an allogeneic stem cell transplant",
              "omopTable": "procedure_occurrence",
              "strategy": "Identify patients with a history of allogeneic stem cell transplantation, which is a significant prior medical procedure.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "stem_cell_transplant"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Undergone an autologous stem cell transplant",
              "omopTable": "procedure_occurrence",
              "strategy": "Identify patients with a history of autologous stem cell transplantation, a significant prior medical procedure.",
              "clinicalCategory": "prior_therapy",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "stem_cell_transplant"
            }
          ]
        }
      },
      "EXC_5.2.4.4": {
        "criterionId": "EXC_5.2.4.4",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active peptic ulcer disease",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with active peptic ulcers, which are a contraindication due to bleeding risk. 'Active' would be inferred from recent diagnosis codes or problem list status.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "gi_hemorrhagic_risk"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Potentially hemorrhagic esophagitis",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with inflammation of the esophagus that has a risk of bleeding. The 'potentially hemorrhagic' aspect may require specific diagnosis codes (e.g., esophagitis with bleeding) or chart review.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "gi_hemorrhagic_risk"
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Potentially hemorrhagic gastritis",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with inflammation of the stomach lining that has a risk of bleeding. The 'potentially hemorrhagic' aspect may require specific diagnosis codes (e.g., gastritis with bleeding) or chart review.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "gi_hemorrhagic_risk"
            }
          ]
        }
      },
      "EXC_5.2.4.5": {
        "criterionId": "EXC_5.2.4.5",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Active immune thrombocytopenic purpura",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies patients with an active diagnosis of the primary disease indication.",
              "clinicalCategory": "disease_indication",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose_of_study_drug",
                "value": 1,
                "unit": "year"
              },
              "operand": {
                "nodeId": "2a",
                "nodeType": "atomic",
                "atomicText": "History of being refractory to platelet transfusions",
                "omopTable": "observation",
                "strategy": "Identifies patients with a clinical history of poor response to platelet transfusions, which is a key indicator of disease severity or type. This often requires manual chart review to confirm.",
                "clinicalCategory": "disease_indication",
                "queryableStatus": "requires_manual"
              }
            }
          ]
        }
      },
      "EXC_5.2.4.6": {
        "criterionId": "EXC_5.2.4.6",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "atomic",
                  "atomicText": "Currently receiving or requires anticoagulation therapy",
                  "omopTable": "drug_exposure",
                  "timeConstraint": "currently",
                  "strategy": "Identifies patients on systemic anticoagulation therapy which poses a potential bleeding risk.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy"
                },
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "Receiving drugs or herbal supplements that affect platelet function",
                  "omopTable": "drug_exposure",
                  "timeConstraint": "currently",
                  "strategy": "Identifies patients on antiplatelet agents (drugs or supplements) which pose a potential bleeding risk.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "anticoagulation_or_antiplatelet_therapy"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Receiving low-dose anticoagulation for central intravenous catheter patency",
              "omopTable": "drug_exposure",
              "valueConstraint": "low-dose AND for catheter patency",
              "timeConstraint": "currently",
              "strategy": "Defines a specific, allowed use of anticoagulants (e.g., heparin flushes) that does not pose a systemic risk and is therefore not an exclusion.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_5.2.4.7": {
        "criterionId": "EXC_5.2.4.7",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 7,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "Received steroid therapy for anti-neoplastic intent",
                "omopTable": "drug_exposure",
                "timeFrameStructured": {
                  "value": 7,
                  "unit": "days",
                  "operator": "within",
                  "relativeEvent": "first_dose"
                },
                "strategy": "Identify patients receiving steroids for cancer treatment, often high-dose systemic steroids like dexamethasone, within the specified timeframe. Intent is key.",
                "clinicalCategory": "prior_therapy",
                "queryableStatus": "partially_queryable"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Received inhaled steroids for asthma",
                  "omopTable": "drug_exposure",
                  "strategy": "Identify use of inhaled corticosteroids (e.g., fluticasone, budesonide) specifically for an asthma indication. This requires linking the drug to the diagnosis.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Received topical steroids",
                  "omopTable": "drug_exposure",
                  "strategy": "Identify use of corticosteroids administered via a topical route (e.g., creams, ointments).",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "fully_queryable"
                },
                {
                  "nodeId": "2c",
                  "nodeType": "atomic",
                  "atomicText": "Received replacement/stress corticosteroids",
                  "omopTable": "drug_exposure",
                  "strategy": "Identify use of corticosteroids for physiological replacement (e.g., Addison's disease) or for stress dosing, which is distinct from anti-neoplastic dosing. This often requires chart review for intent.",
                  "clinicalCategory": "prior_therapy",
                  "queryableStatus": "requires_manual"
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.4.8": {
        "criterionId": "EXC_5.2.4.8",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 7,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Received aspirin",
            "omopTable": "drug_exposure",
            "timeConstraint": "within 7 days prior to the first dose of study drug",
            "timeFrameStructured": {
              "value": 7,
              "unit": "days",
              "operator": "within",
              "relativeEvent": "first_dose"
            },
            "strategy": "Query for drug exposure records for aspirin within the 7-day window preceding the first dose of the study drug.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable"
          }
        }
      },
      "EXC_5.2.4.9": {
        "criterionId": "EXC_5.2.4.9",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "first_dose",
                "value": 14,
                "unit": "days"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "operator",
                "operator": "OR",
                "operands": [
                  {
                    "nodeId": "1a1",
                    "nodeType": "atomic",
                    "atomicText": "Received chemotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for exposure to chemotherapy drugs within the defined time frame.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a2",
                    "nodeType": "atomic",
                    "atomicText": "Received immunotherapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for exposure to immunotherapy agents within the defined time frame.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a3",
                    "nodeType": "atomic",
                    "atomicText": "Received radiotherapy",
                    "omopTable": "procedure_occurrence",
                    "strategy": "Check for radiotherapy procedures within the defined time frame.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "anti_cancer_therapy"
                  },
                  {
                    "nodeId": "1a4",
                    "nodeType": "operator",
                    "operator": "EXCEPT",
                    "operands": [
                      {
                        "nodeId": "1a4a",
                        "nodeType": "atomic",
                        "atomicText": "Received hormonal anti-cancer therapy",
                        "omopTable": "drug_exposure",
                        "strategy": "Identify all hormonal therapies used for cancer treatment.",
                        "clinicalCategory": "prior_therapy",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "anti_cancer_therapy"
                      },
                      {
                        "nodeId": "1a4b",
                        "nodeType": "operator",
                        "operator": "OR",
                        "operands": [
                          {
                            "nodeId": "1a4b1",
                            "nodeType": "atomic",
                            "atomicText": "Received hormones for thyroid conditions",
                            "omopTable": "drug_exposure",
                            "strategy": "Identify hormone therapies for thyroid conditions, which are explicitly allowed.",
                            "clinicalCategory": "prior_therapy",
                            "queryableStatus": "fully_queryable"
                          },
                          {
                            "nodeId": "1a4b2",
                            "nodeType": "atomic",
                            "atomicText": "Received estrogen replacement therapy (ERT)",
                            "omopTable": "drug_exposure",
                            "strategy": "Identify estrogen replacement therapies, which are explicitly allowed.",
                            "clinicalCategory": "prior_therapy",
                            "queryableStatus": "fully_queryable"
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "nodeId": "1a5",
                    "nodeType": "atomic",
                    "atomicText": "Received any investigational therapy",
                    "omopTable": "drug_exposure",
                    "strategy": "Check for exposure to drugs known to be investigational or part of other clinical trials. This may require a specific value set.",
                    "clinicalCategory": "prior_therapy",
                    "queryableStatus": "partially_queryable"
                  }
                ]
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "NOT",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Recovered to less than grade 2 from clinically significant adverse effects of previous therapy",
                  "omopTable": "observation",
                  "numericConstraintStructured": {
                    "value": 2,
                    "operator": "<",
                    "unit": "grade",
                    "parameter": "CTCAE grade of residual toxicity from prior therapy"
                  },
                  "strategy": "Check for unresolved, clinically significant toxicities from any prior therapy. This requires manual review to confirm the grade, significance, and attribution of the toxicity.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "requires_manual"
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.4.10": {
        "criterionId": "EXC_5.2.4.10",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 30,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Received a biologic agent",
            "omopTable": "drug_exposure",
            "strategy": "This is a standard washout period requirement for prior biologic therapies to prevent interference with the study drug's efficacy or safety assessment.",
            "clinicalCategory": "prior_therapy",
            "queryableStatus": "fully_queryable"
          }
        }
      },
      "EXC_5.2.4.11": {
        "criterionId": "EXC_5.2.4.11",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 3,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "operator",
            "operator": "OR",
            "operands": [
              {
                "nodeId": "1a1",
                "nodeType": "atomic",
                "atomicText": "Consumed grapefruit",
                "omopTable": "observation",
                "timeConstraint": "within 3 days prior to the first dose of study drug",
                "strategy": "Grapefruit and its products can interfere with the metabolism of certain drugs (e.g., via CYP3A4 inhibition). This is a common safety exclusion to ensure predictable drug exposure.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "grapefruit_consumption"
              },
              {
                "nodeId": "1a2",
                "nodeType": "atomic",
                "atomicText": "Consumed grapefruit products",
                "omopTable": "observation",
                "timeConstraint": "within 3 days prior to the first dose of study drug",
                "strategy": "Grapefruit and its products can interfere with the metabolism of certain drugs (e.g., via CYP3A4 inhibition). This is a common safety exclusion to ensure predictable drug exposure.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "requires_manual",
                "clinicalConceptGroup": "grapefruit_consumption"
              }
            ]
          }
        }
      },
      "EXC_5.2.4.12": {
        "criterionId": "EXC_5.2.4.12",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "temporal",
                  "temporalConstraint": {
                    "operator": "WITHIN",
                    "anchor": "study_participation",
                    "value": 6,
                    "unit": "months"
                  },
                  "operand": {
                    "nodeId": "1a_op",
                    "nodeType": "operator",
                    "operator": "OR",
                    "operands": [
                      {
                        "nodeId": "1a_op_1",
                        "nodeType": "atomic",
                        "atomicText": "Myocardial infarction",
                        "omopTable": "condition_occurrence",
                        "strategy": "Identifies a specific recent cardiovascular event.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "significant_cardiovascular_disease"
                      },
                      {
                        "nodeId": "1a_op_2",
                        "nodeType": "atomic",
                        "atomicText": "Thrombotic event",
                        "omopTable": "condition_occurrence",
                        "strategy": "Identifies a specific recent cardiovascular event.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "significant_cardiovascular_disease"
                      },
                      {
                        "nodeId": "1a_op_3",
                        "nodeType": "atomic",
                        "atomicText": "Thromboembolic event",
                        "omopTable": "condition_occurrence",
                        "strategy": "Identifies a specific recent cardiovascular event.",
                        "clinicalCategory": "safety_exclusion",
                        "queryableStatus": "fully_queryable",
                        "clinicalConceptGroup": "significant_cardiovascular_disease"
                      }
                    ]
                  }
                },
                {
                  "nodeId": "1b",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of cardiovascular disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Captures general history of cardiovascular disease not covered by the specific recent events. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable",
                  "clinicalConceptGroup": "significant_cardiovascular_disease"
                },
                {
                  "nodeId": "1c",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of renal disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant kidney disease. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1d",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of neurologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant neurological conditions. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1e",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of psychiatric disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant psychiatric conditions. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1f",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of endocrinologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant endocrine disorders. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1g",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of metabolic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant metabolic disorders. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1h",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of immunologic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant immunological conditions. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "1i",
                  "nodeType": "atomic",
                  "atomicText": "Significant history of hepatic disease",
                  "omopTable": "condition_occurrence",
                  "strategy": "Checks for history of clinically significant liver disease. The term 'significant' requires clinical judgment.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Disease history would adversely affect participation in the study in the opinion of the investigator",
              "omopTable": "observation",
              "strategy": "This is a subjective assessment by the investigator that a subject's medical history makes them unsuitable for the study. It applies to any of the identified conditions.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "EXC_5.2.4.13": {
        "criterionId": "EXC_5.2.4.13",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Subject is female",
              "omopTable": "person",
              "strategy": "Identifies the gender of the subject as female.",
              "clinicalCategory": "demographics",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Subject is pregnant",
                  "omopTable": "observation",
                  "strategy": "Identifies if the subject has a current pregnancy status, typically found through observation codes or specific condition codes.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "pregnancy_lactation_status"
                },
                {
                  "nodeId": "2b",
                  "nodeType": "atomic",
                  "atomicText": "Subject is breast-feeding",
                  "omopTable": "observation",
                  "strategy": "Identifies if the subject is currently breast-feeding (lactating), typically found through observation codes.",
                  "clinicalCategory": "demographics",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "pregnancy_lactation_status"
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.4.14": {
        "criterionId": "EXC_5.2.4.14",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "atomic",
          "atomicText": "Tested positive for HIV",
          "omopTable": "measurement",
          "valueConstraint": "Positive",
          "strategy": "The criterion excludes subjects with HIV due to potential drug-drug interactions between anti-retroviral medications and ABT-263, and the risk of lymphopenia increasing susceptibility to opportunistic infections.",
          "clinicalCategory": "safety_exclusion",
          "queryableStatus": "fully_queryable"
        }
      },
      "EXC_5.2.4.15": {
        "criterionId": "EXC_5.2.4.15",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "EXCEPT",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "study_entry",
                "value": 3,
                "unit": "years"
              },
              "operand": {
                "nodeId": "1a",
                "nodeType": "atomic",
                "atomicText": "History of other active malignancy",
                "omopTable": "condition_occurrence",
                "timeConstraint": "within the past 3 years prior to study entry",
                "timeFrameStructured": {
                  "value": 3,
                  "unit": "years",
                  "operator": "within",
                  "relativeEvent": "study_entry"
                },
                "strategy": "Identifies subjects with a recent history of other active cancers, which is the primary exclusionary condition.",
                "clinicalCategory": "safety_exclusion",
                "queryableStatus": "partially_queryable"
              }
            },
            {
              "nodeId": "2",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "2a",
                  "nodeType": "atomic",
                  "atomicText": "Adequately treated in situ carcinoma of the cervix uteri",
                  "omopTable": "condition_occurrence",
                  "strategy": "Exception for a non-invasive, treated cervical cancer.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "partially_queryable"
                },
                {
                  "nodeId": "2b1",
                  "nodeType": "atomic",
                  "atomicText": "Basal cell carcinoma of the skin",
                  "omopTable": "condition_occurrence",
                  "strategy": "Exception for a common, low-risk non-melanoma skin cancer.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "non_melanoma_skin_cancer"
                },
                {
                  "nodeId": "2b2",
                  "nodeType": "atomic",
                  "atomicText": "Squamous cell carcinoma of the skin",
                  "omopTable": "condition_occurrence",
                  "strategy": "Exception for a common, low-risk non-melanoma skin cancer.",
                  "clinicalCategory": "safety_exclusion",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "non_melanoma_skin_cancer"
                },
                {
                  "nodeId": "2c",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "2c1",
                      "nodeType": "atomic",
                      "atomicText": "Previous malignancy confined",
                      "omopTable": "observation",
                      "strategy": "Part of a composite exception for prior cancers that are considered cured. 'Confined' refers to staging information.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual"
                    },
                    {
                      "nodeId": "2c2",
                      "nodeType": "atomic",
                      "atomicText": "Previous malignancy surgically resected",
                      "omopTable": "procedure_occurrence",
                      "strategy": "Part of a composite exception for prior cancers that are considered cured.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "2c3",
                      "nodeType": "atomic",
                      "atomicText": "Surgical resection was with curative intent",
                      "omopTable": "observation",
                      "strategy": "Part of a composite exception for prior cancers that are considered cured. 'Curative intent' is a clinical judgment.",
                      "clinicalCategory": "safety_exclusion",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                }
              ]
            }
          ]
        }
      },
      "EXC_5.2.4.16": {
        "criterionId": "EXC_5.2.4.16",
        "type": "exclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "OR",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Uncontrolled systemic infection (viral, bacterial, or fungal)",
              "omopTable": "condition_occurrence",
              "strategy": "Identifies subjects with active, unmanaged systemic infections which pose a safety risk.",
              "clinicalCategory": "safety_exclusion",
              "queryableStatus": "partially_queryable",
              "clinicalConceptGroup": "uncontrolled_conditions"
            },
            {
              "nodeId": "2",
              "nodeType": "temporal",
              "temporalConstraint": {
                "operator": "WITHIN",
                "anchor": "study drug administration",
                "value": 1,
                "unit": "weeks"
              },
              "operand": {
                "nodeId": "2a",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "2a1",
                    "nodeType": "atomic",
                    "atomicText": "Diagnosis of fever",
                    "omopTable": "condition_occurrence",
                    "timeConstraint": "within one week prior to study drug administration",
                    "timeFrameStructured": {
                      "value": 1,
                      "unit": "weeks",
                      "operator": "within",
                      "relativeEvent": "study drug administration"
                    },
                    "strategy": "Identifies the fever component of febrile neutropenia, a serious condition.",
                    "clinicalCategory": "safety_exclusion",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "febrile_neutropenia"
                  },
                  {
                    "nodeId": "2a2",
                    "nodeType": "atomic",
                    "atomicText": "Diagnosis of neutropenia",
                    "omopTable": "condition_occurrence",
                    "timeConstraint": "within one week prior to study drug administration",
                    "timeFrameStructured": {
                      "value": 1,
                      "unit": "weeks",
                      "operator": "within",
                      "relativeEvent": "study drug administration"
                    },
                    "strategy": "Identifies the neutropenia component of febrile neutropenia, indicating a compromised immune state.",
                    "clinicalCategory": "safety_exclusion",
                    "queryableStatus": "fully_queryable",
                    "clinicalConceptGroup": "febrile_neutropenia"
                  }
                ]
              }
            }
          ]
        }
      },
      "EXC_5.2.4.17": {
        "criterionId": "EXC_5.2.4.17",
        "type": "exclusion",
        "tree": {
          "nodeId": "1",
          "nodeType": "temporal",
          "temporalConstraint": {
            "operator": "WITHIN",
            "anchor": "first_dose",
            "value": 7,
            "unit": "days"
          },
          "operand": {
            "nodeId": "1a",
            "nodeType": "atomic",
            "atomicText": "Received known CYP3A inhibitors",
            "omopTable": "drug_exposure",
            "valueConstraint": "e.g., ketoconazole",
            "timeConstraint": "within 7 days prior to first dose of study drug",
            "strategy": "This is a safety exclusion to prevent potential drug-drug interactions. CYP3A inhibitors can increase the concentration and toxicity of study drugs that are metabolized by the CYP3A enzyme.",
            "clinicalCategory": "safety_exclusion",
            "queryableStatus": "fully_queryable",
            "clinicalConceptGroup": "cyp3a_inhibitors"
          }
        }
      },
      "INC_5.2.5.1": {
        "criterionId": "INC_5.2.5.1",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "1a",
                  "nodeType": "operator",
                  "operator": "EXCEPT",
                  "operands": [
                    {
                      "nodeId": "1a1",
                      "nodeType": "atomic",
                      "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 1",
                      "omopTable": "observation",
                      "strategy": "This is a high-level reference to the complete set of I/E criteria from the Phase 1 study. In a full implementation, this node would be replaced by the entire expression tree for the Phase 1 criteria.",
                      "clinicalCategory": "diagnostic_confirmation",
                      "queryableStatus": "requires_manual"
                    },
                    {
                      "nodeId": "1a2",
                      "nodeType": "atomic",
                      "atomicText": "Laboratory parameters from Phase 1",
                      "omopTable": "measurement",
                      "strategy": "This represents the subset of Phase 1 criteria that are based on laboratory values. These are explicitly excluded from the re-evaluation for the Extension Study.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                },
                {
                  "nodeId": "1b",
                  "nodeType": "operator",
                  "operator": "EXCEPT",
                  "operands": [
                    {
                      "nodeId": "1b1",
                      "nodeType": "atomic",
                      "atomicText": "Meets all Inclusion and Exclusion criteria from Phase 2a",
                      "omopTable": "observation",
                      "strategy": "This is a high-level reference to the complete set of I/E criteria from the Phase 2a study. In a full implementation, this node would be replaced by the entire expression tree for the Phase 2a criteria.",
                      "clinicalCategory": "diagnostic_confirmation",
                      "queryableStatus": "requires_manual"
                    },
                    {
                      "nodeId": "1b2",
                      "nodeType": "atomic",
                      "atomicText": "Laboratory parameters from Phase 2a",
                      "omopTable": "measurement",
                      "strategy": "This represents the subset of Phase 2a criteria that are based on laboratory values. These are explicitly excluded from the re-evaluation for the Extension Study.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "requires_manual"
                    }
                  ]
                }
              ]
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Stable lab values per applicable laboratory reference ranges",
              "omopTable": "measurement",
              "strategy": "This condition requires a clinical assessment to determine if a subject's laboratory values are 'stable', meaning they are not changing in a clinically significant way.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "requires_manual"
            }
          ]
        }
      },
      "INC_5.2.5.2": {
        "criterionId": "INC_5.2.5.2",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1a",
              "nodeType": "atomic",
              "atomicText": "Platelet count >= 25,000/mm3 (untransfused)",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 25000,
                "operator": ">=",
                "unit": "/mm3",
                "parameter": "Platelets"
              },
              "strategy": "The '(untransfused)' qualifier requires checking that the lab result was not influenced by a recent platelet transfusion, making it partially queryable.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "1b",
              "nodeType": "operator",
              "operator": "IMPLICATION",
              "condition": {
                "nodeId": "1b_cond",
                "nodeType": "atomic",
                "atomicText": "Platelet count <= 50,000/mm3",
                "omopTable": "measurement",
                "numericConstraintStructured": {
                  "value": 50000,
                  "operator": "<=",
                  "unit": "/mm3",
                  "parameter": "Platelets"
                },
                "strategy": "This is the condition that triggers the requirement for stability and increased monitoring.",
                "clinicalCategory": "organ_function",
                "queryableStatus": "fully_queryable"
              },
              "requirement": {
                "nodeId": "1b_req",
                "nodeType": "operator",
                "operator": "AND",
                "operands": [
                  {
                    "nodeId": "1b_req1",
                    "nodeType": "atomic",
                    "atomicText": "Platelet count is stable",
                    "omopTable": "observation",
                    "strategy": "Assessment of stability requires clinical judgment and review of multiple data points over time.",
                    "clinicalCategory": "organ_function",
                    "queryableStatus": "requires_manual"
                  },
                  {
                    "nodeId": "1b_req2",
                    "nodeType": "atomic",
                    "atomicText": "Platelet count is monitored at an increased frequency at the discretion of the investigator",
                    "omopTable": "observation",
                    "strategy": "This requirement is procedural and depends on investigator discretion, requiring manual confirmation.",
                    "clinicalCategory": "organ_function",
                    "queryableStatus": "requires_manual"
                  }
                ]
              }
            },
            {
              "nodeId": "2a",
              "nodeType": "atomic",
              "atomicText": "Absolute Neutrophil count (ANC) >= 500/uL",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 500,
                "operator": ">=",
                "unit": "/\u03bcL",
                "parameter": "Absolute Neutrophil Count"
              },
              "strategy": "Standard lab value requirement for neutrophil count.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "2b",
              "nodeType": "operator",
              "operator": "IMPLICATION",
              "condition": {
                "nodeId": "2b_cond",
                "nodeType": "atomic",
                "atomicText": "Absolute Neutrophil count (ANC) is between 500/uL and 1000/uL",
                "omopTable": "measurement",
                "numericRangeStructured": {
                  "min": 500,
                  "max": 999.99,
                  "unit": "/\u03bcL",
                  "parameter": "Absolute Neutrophil Count"
                },
                "strategy": "This is the condition (ANC >= 500 and < 1000) that triggers the increased monitoring requirement.",
                "clinicalCategory": "organ_function",
                "queryableStatus": "fully_queryable"
              },
              "requirement": {
                "nodeId": "2b_req",
                "nodeType": "atomic",
                "atomicText": "ANC is monitored at an increased frequency at the discretion of the investigator",
                "omopTable": "observation",
                "strategy": "This requirement is procedural and depends on investigator discretion, requiring manual confirmation.",
                "clinicalCategory": "organ_function",
                "queryableStatus": "requires_manual"
              }
            },
            {
              "nodeId": "3",
              "nodeType": "atomic",
              "atomicText": "Hemoglobin >= 8.0 g/dL",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 8.0,
                "operator": ">=",
                "unit": "g/dL",
                "parameter": "Hemoglobin"
              },
              "strategy": "Standard lab value requirement for hemoglobin.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "4a",
              "nodeType": "atomic",
              "atomicText": "aPTT not to exceed 1.2 x ULN",
              "omopTable": "measurement",
              "valueConstraint": "value <= 1.2 * Upper Limit of Normal",
              "strategy": "Coagulation parameter relative to the institution's upper limit of normal (ULN), which varies by lab.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "4b",
              "nodeType": "atomic",
              "atomicText": "PT not to exceed 1.2 x ULN",
              "omopTable": "measurement",
              "valueConstraint": "value <= 1.2 * Upper Limit of Normal",
              "strategy": "Coagulation parameter relative to the institution's upper limit of normal (ULN), which varies by lab.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            }
          ]
        }
      },
      "INC_5.2.5.3": {
        "criterionId": "INC_5.2.5.3",
        "type": "inclusion",
        "tree": {
          "nodeId": "root",
          "nodeType": "operator",
          "operator": "AND",
          "operands": [
            {
              "nodeId": "1",
              "nodeType": "atomic",
              "atomicText": "Chemistry values do not exceed Grade 2",
              "omopTable": "measurement",
              "valueConstraint": "values must be <= Grade 2 per CTCAE",
              "strategy": "General safety requirement for all chemistry labs, unless a more specific limit is provided.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "partially_queryable"
            },
            {
              "nodeId": "2",
              "nodeType": "atomic",
              "atomicText": "Serum creatinine <= 3.0 x ULN",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 3.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "Serum creatinine"
              },
              "strategy": "Ensures adequate renal function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable"
            },
            {
              "nodeId": "3a",
              "nodeType": "atomic",
              "atomicText": "AST <= 5.0 x ULN",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 5.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "AST"
              },
              "strategy": "Ensures adequate liver function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "liver_function_tests"
            },
            {
              "nodeId": "3b",
              "nodeType": "atomic",
              "atomicText": "ALT <= 5.0 x ULN",
              "omopTable": "measurement",
              "numericConstraintStructured": {
                "value": 5.0,
                "operator": "<=",
                "unit": "x ULN",
                "parameter": "ALT"
              },
              "strategy": "Ensures adequate liver function.",
              "clinicalCategory": "organ_function",
              "queryableStatus": "fully_queryable",
              "clinicalConceptGroup": "liver_function_tests"
            },
            {
              "nodeId": "4",
              "nodeType": "operator",
              "operator": "OR",
              "operands": [
                {
                  "nodeId": "4a",
                  "nodeType": "atomic",
                  "atomicText": "Bilirubin <= 3.0 x ULN",
                  "omopTable": "measurement",
                  "numericConstraintStructured": {
                    "value": 3.0,
                    "operator": "<=",
                    "unit": "x ULN",
                    "parameter": "Bilirubin"
                  },
                  "strategy": "Primary requirement for bilirubin level to ensure adequate liver function.",
                  "clinicalCategory": "organ_function",
                  "queryableStatus": "fully_queryable",
                  "clinicalConceptGroup": "bilirubin_level"
                },
                {
                  "nodeId": "4b",
                  "nodeType": "operator",
                  "operator": "AND",
                  "operands": [
                    {
                      "nodeId": "4b1",
                      "nodeType": "atomic",
                      "atomicText": "Subject has Gilbert's Syndrome",
                      "omopTable": "condition_occurrence",
                      "strategy": "Identifies subjects eligible for the bilirubin exception.",
                      "clinicalCategory": "disease_indication",
                      "queryableStatus": "fully_queryable"
                    },
                    {
                      "nodeId": "4b2",
                      "nodeType": "atomic",
                      "atomicText": "Bilirubin > 3.0 x ULN approved by investigator and medical monitor",
                      "omopTable": "observation",
                      "strategy": "Requires manual override for subjects with Gilbert's Syndrome and elevated bilirubin.",
                      "clinicalCategory": "organ_function",
                      "queryableStatus": "requires_manual",
                      "clinicalConceptGroup": "bilirubin_level"
                    }
                  ]
                }
              ]
            }
          ]
        }
      }
    }
  },
  "funnelStages": [
    {
      "stageId": "S2",
      "stageName": "Demographics",
      "stageOrder": 2,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0023",
        "A0024",
        "A0025",
        "A0026",
        "A0027",
        "A0028",
        "A0029",
        "A0030",
        "A0031",
        "A0032",
        "A0033",
        "A0034",
        "A0035",
        "A0036",
        "A0037",
        "A0084",
        "A0085",
        "A0086",
        "A0110",
        "A0111",
        "A0112",
        "A0113",
        "A0114",
        "A0115",
        "A0116",
        "A0117",
        "A0118",
        "A0119",
        "A0120",
        "A0121",
        "A0122",
        "A0123",
        "A0124",
        "A0168",
        "A0169",
        "A0170"
      ],
      "estimatedEliminationRate": 0.0
    },
    {
      "stageId": "S4",
      "stageName": "Treatment History",
      "stageOrder": 4,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0053",
        "A0055",
        "A0057",
        "A0061",
        "A0062",
        "A0063",
        "A0064",
        "A0069",
        "A0090",
        "A0091",
        "A0138",
        "A0140",
        "A0144",
        "A0145",
        "A0153"
      ],
      "estimatedEliminationRate": 36.0
    },
    {
      "stageId": "S7",
      "stageName": "Safety Exclusions",
      "stageOrder": 7,
      "stageLogic": "AND",
      "criteriaIds": [
        "A0042",
        "A0043",
        "A0046",
        "A0047",
        "A0048",
        "A0049",
        "A0050",
        "A0052",
        "A0056",
        "A0065",
        "A0068",
        "A0070",
        "A0071",
        "A0072",
        "A0073",
        "A0074",
        "A0075",
        "A0076",
        "A0077",
        "A0078",
        "A0079",
        "A0080",
        "A0081",
        "A0082",
        "A0083",
        "A0126",
        "A0127",
        "A0130",
        "A0131",
        "A0149",
        "A0152",
        "A0154",
        "A0155",
        "A0156",
        "A0157",
        "A0158",
        "A0159",
        "A0160",
        "A0161",
        "A0162",
        "A0163",
        "A0164",
        "A0165",
        "A0166",
        "A0167",
        "A0171",
        "A0172",
        "A0173",
        "A0174",
        "A0175",
        "A0176",
        "A0177",
        "A0178",
        "A0179",
        "A0180",
        "A0181",
        "A0182"
      ],
      "estimatedEliminationRate": 16.666666666666668
    }
  ],
  "metadata": {
    "totalAtomics": 204,
    "totalGroups": 108,
    "totalStages": 3,
    "stagesWithQueries": 81,
    "stagesWithFhir": 81
  }
}